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ABSTRACT 
MONICA L. FRAZIER: The Yersinia pestis Autotransporter YapG Contains a Fast Folding 
 β-helix Domain 
(Under the direction of Matthew Redinbo) 
 
Autotransporter proteins are the most widely secreted protein family in gram-
negative bacteria; their passenger domains are predicted to be β-helical in 97% of cases. 
The β-helical fold has been hitherto understudied with respect to protein folding, which 
typically is centered on small α-helical, low contact order proteins. In contrast, the β-helical 
portions of passenger domains are typically large, and made up of unique structural repeats 
with high contact order. Here, we have studied the in vitro folding of the passenger domain 
of YapG, an autotransporter from Yersinia pestis, via thermodynamic and kinetic 
approaches. We have identified YapG as the fastest refolding passenger domain to date. 
Steady-state fluorescence and circular dichroism indicate a one-step folding process; 
however, stopped-flow fluorescence indicates a one-step unfolding and a two-step refolding. 
Neither proline isomerization nor aggregation is associated with YapG refolding, suggesting 
this fast folding β-helix may experience a general collapse followed by a slower fine tuning 
folding step. In addition, gel filtration studies of the refolded state indicate that YapG may 
refold into two different folded species. Taken together, these results provide the first 
biophysical analysis of an autotransporter passenger domain from Y. pestis and provide 
new insight into the folding process in β-helical folds.    
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CHAPTER 1 
The Yersinia pestis autotransporter YapG contains a fast folding β-helical domain* 
 
 
1.1 Introduction 
1.1.1 Autotransporter Protein Passenger Domains 
Autotransporter proteins represent the largest class of secreted proteins from gram-
negative bacteria, and are the primary component of type V secretion (1).  Specialized for 
protein transport out of the two gram-negative bacterial membranes, autotransporters are 
made up of an N-terminal signal sequence, a C-terminal β-barrel called the autotransporter 
domain, and an interior, functional, passenger domain (2). The N-terminal signal sequence 
is used to shuttle the unfolded passenger and autotransporter domains through the Sec 
translocon of the inner membrane. The C-terminal β-barrel is then folded into the outer 
membrane of the bacterium, and is utilized as a transport vehicle for the passenger domain 
peptide out of the bacterium. The shuttling of the passenger domain is not energy 
dependent (does not require ATP) and requires the passenger domain to remain minimally 
folded (3, 4). The mechanism of this transport is highly debated, as is the degree to which 
autotransporters facilitate their own transport versus aid from chaperone proteins (1, 5).   
Once on the exterior of the bacterium, the passenger domain has three potential end 
locations; they may remain covalently attached to the β-barrel, be cleaved from the β-barrel  
2 
but remain localized to the membrane, or be cleaved from the β-barrel and secreted away 
from the membrane. These three options are likely associated with the virulence related 
functions of passenger domains, which includes adhesins, proteases, toxins, and esterases 
among others (6). However, relative to the ubiquitous nature of autotransporter expression 
in gram-negative bacteria, few passenger domains have been characterized.   
 
1.1.2 Passenger Domains and the β-helical Fold 
Despite wide variability in length and sequence, over 97% of passenger domains 
from autotransporters are predicted to have a right-handed β-helical fold (7).  The β-helical 
fold is made up of repeating coils of 3 β-strands connected by variable length loops, with 
coils repeating on one another to create 3 parallel β-sheets. These coils create a long 
triangularly shaped domain; each coil has a rise of 4.86 Å (8).  
The crystal structures of several β-helices have been solved: P.69 pertactin from 
Bordetella pertussis (PDBID: 1dab), hemoglobin protease Hbp (PDBID: 1WXR) and the 
extracellular serine protease EspP (PDBID: 3SZE), both from pathogenic Escherichia coli, 
the vacuolating toxin p55 VacA from Helicobacter pylori (PDBID: 2QV3), and 
Immunoglobulin A1 Protease from Haemophilus influenza (PDBID: 3H09)   (9-13). The 
majority of these heretofore solved crystal structures have provided some insight into the 
significance of the β-helical fold, including the theory that the fold was evolved for transport, 
not function (7). Indeed, several of the passenger domains above include globular domains 
protruding off the β-helical spine associated with their function as serine protease 
autotransporters of the Enterobacteriacaea (SPATEs) (9, 11, 12). However, pertactin is a 
much simpler structure made up nearly exclusively with β-spine, with an RGD sequence 
3 
motif associated with its function as an adhesin found in one of the loop regions between the 
β-coils (10). 
β-helices are particularly interesting from a protein folding perspective because they 
represent a protein class that has hitherto been understudied by the protein folding 
community. Not only are β-helices made up of purely β-strand secondary structure (no α-
helical content), but they are structural repeat proteins with an associated high contact order 
and surprisingly low sequence identity despite high structural identity. Only a few β-helical 
proteins have been biophysically characterized, two of which are passenger domains from 
autotransporter proteins.  
Pertactin and Pet, two passenger domains from Bordetella pertussis and Escherichia 
coli, respectively, have both been shown to fold in a three-state process under equilibrium 
denaturing conditions with the C-terminal end of the passenger domain folding first as a 
stable core and the N-terminus following (7, 14). Pertactin refolding using time-resolved 
stopped-flow fluorescence has been found to be extremely slow (on the order of hours) and 
resistant to aggregation (7, 15). However, different from results seen in Pertactin and Pet, 
the P22 tailspike protein and pectate lyase C have been found to undergo a two-state 
transition from folded to unfolded under equilibrium denaturing conditions (16-18). It remains 
unclear whether the refolding speed or folding pathway of these proteins seen in vitro plays 
any role in the biological function of these proteins.  
 
1.1.3 YapG 
Yersinia pestis, the gram negative bacterium responsible for bubonic, pneumonic 
and septicemic forms of the plague has 9 putative autotransporter proteins that have been 
found using in silico analyses (Yaps C, E, F, G, H, J, K, L, and M) (19). The passenger 
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domains of these autotransporters (Yaps, for Yersinia pestis autotransporter proteins) are 
hypothesized to have virulence associated functions; YapE has been found to be essential 
for full Y. pestis virulence (20).  The Yaps have passenger domains of variable length (359-
3347 amino acids) and sequence (19).  
YapG, a 994 amino acid autotransporter, is unique from the other Yaps because it is 
fully secreted (19) and it is the one of only two Yaps (G and H) to have repeat regions within 
the passenger domain. Three repeats (the first two are identical and the third is nearly 
identical), are found within the C-terminus of the passenger domain (Figure 1.1), and all 
repeats contain sites within the described recognition sequences for the plasminogen 
activator Pla, an outer membrane surface protease in Y. pestis (21). YapG also contains a 
KDEL sequence motif, which may be associated with retention in the endoplasmic reticulum 
of targeted cells. 
In this work we have overexpressed, refolded, and purified the YapG passenger 
domain and investigated its fold and structure via equilibrium and time resolved kinetic 
biophysical studies. We have demonstrated that the secreted passenger domain from YapG 
is a model β-helix not expected to contain any additional globular domains. Steady-state 
Circular Dichroism and intrinsic fluorescence measurements in the presence of denaturant 
indicate a single transition from the native state to the unfolded state, but time-resolved 
kinetics reveal multi-state folding behavior. Unlike previously studied β-helices, the YapG 
passenger folds extremely quickly and without formation of aggregates or rate limitation from 
proline isomerization. The speed of YapG folding contradicts previous notions that 
passenger domains fold purposefully slow to ensure folding does not occur until full 
secretion from bacteria (15) . Taken together, these results provide the first biophysical 
analysis of an autotransporter passenger domain in Y. pestis and provide new insight into 
the folding process in β-helical folds. 
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1.2 Results 
1.2.1 Construct Design 
The YapG passenger domain extends from the end of the signal sequence on the N-
terminus to the start of the C-terminal autotransporter domain (Figure 1.1). SignalP 3.0, a 
server that predicts signal peptide cleavage sites, predicts the signal sequence to be 
cleaved between Ala49 and Asn50 (Figure 1.2) (22, 23). The end of the passenger domain 
was predicted using the Pfam protein family database (24) by locating the predicted start of 
the autotransporter domain (residue 718); the C-terminal residue of the YapG passenger is 
predicted to be at residue 717 (Figure 1.1).  
Homology modeling of YapG50-717 gave insight into the nature of the passenger 
domain’s tertiary structure (Figure 1.3). The overall fold modeled for the YapG passenger is 
of a β-helical spine (see Figure 1.3B for a magnification of the β-helical spine), with variable 
length loops connecting the β-strands of the helix. Beginning at residue 480, the YapG50-717 
homology model predicts a long region of unstructured sequence that extends to the C-
terminus of the passenger domain. In addition, this region (residue 480 onward) of the YapG 
passenger domain sequence contains a proline-rich region (23 of the passenger domain’s 
29 proline residues).  Proline cis/trans isomerization is often considered to be the rate 
limiting step in protein folding (25). To overcome these issues, the YapG50-479 construct was 
designed and created using ligation independent cloning. The 50-479 construct should 
maintain a regular secondary structure and not involve the long unstructured region 
containing proline rich sequence. Thus, the 50-479 construct was generated with 
crystallization in mind.  
The model’s long unstructured region (480-717) contains YapG’s repeat region 
(Figure 1.1), where the surface protease Pla has been shown to cleave YapG from the 
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surface of Y. pestis in at least 3 different places (KR sequences predicted to be cleavage 
sites are marked in Figure 1.1 and shown in magenta spheres in Figure 1.3A). Mutagenesis 
of the putative cleavage sites has shown that the first cleavage occurs after residue 512 
(Chelsea Lane, Ph.D., Miller lab, data not shown). Thus, it is assumed the functional region 
of the YapG passenger is within the YapG50-512 construct. This construct was also created 
using ligation independent cloning and was considered the most biologically relevant 
construct. YapG50-512 was used for all studies with the exception of crystallization trials.  
 
1.2.2 The YapG Passenger Domain is β-Helical  
Multiple prediction servers were used to evaluate the secondary structure of YapG’s 
passenger. PSIPRED (PSIPRED V3.0) (26, 27) predicted the entire sequence to be α-helix 
free, consisting of only coil and β-strand segments. Likewise, Jpred (28, 29) predicts a 
purely β-strand structure. PredictProtein (www.predictprotein.org) predicts YapG50-512 to be 
0.0% helix, 48.4% strand, and 51.6% loop (30). All servers predicted YapG to be made up of 
β-strands of varying length (3-16 residues) connected by loops also varying in length 
(approximately 2-15 residues). This pattern was considered well in line with the canonical 
makeup of a β-helix (see 1.1.2).  
The β-helix prediction program BetaWrap (31) was used to compare the YapG 
passenger domain’s raw score with other known β-helices. BetaWrap scores a query 
sequence against known β-helical structures for the potential of the query to fit into the 
interacting and stacking residues of those structures. Each score is given a P-value 
associated with the probability that the same score would be attained using a template from 
the PDB that is not a β-helix. The YapG50-512 construct has a raw score of -22.28 (P-value of 
0.0072) for residues 29-157, chosen as the “Best Wrap”. This score is in line with other 
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known β-helices (Pet, Hbp, and pertactin have scores of -21.93, -21.27, and -18.2 with P-
values of 0.0048, 1 x 10-5, and 0.0021, respectively) and suggests that YapG’s passenger 
domain has a β-helical fold (14). 
The YapG constructs were overexpressed and refolded from inclusion bodies after 
extensive optimization of the refolding protocol. Refolding success was evaluated based on 
elution from gel filtration at an expected volume in a singular, symmetrical peak, the ratio of 
soluble protein eluted to soluble aggregate eluted in the void volume, and with a Circular 
Dichroism (CD) wavelength spectrum.  
 The CD wavelength spectrum of purified, refolded YapG50-512 was used to observe 
the native secondary structure of the protein. Purified YapG50-512 displays a canonical β-
helical CD wavelength spectrum (Figure 1.4A, solid downward triangles). The minimum at 
215 nm is expected for a protein containing β-strands. No signal is seen for the canonical α-
helical minima at 208 nm or 222 nm, indicating predictions that YapG50-512 is purely β-helical 
are correct. The CD spectrum for YapG50-512 is very similar to those seen for other 
passenger domains (14, 32, 33). Taken together, the BetaWrap score, secondary structural 
predictions, and the CD spectrum suggest the YapG50-512 construct is a model β-helix, and 
does not contain any additional globular domains within its passenger. 
 
1.2.3 Thermal Stability of YapG50-512 
 Thermal denaturation of YapG50-512 from 10 °C to 90 °C was carried out to determine 
the melting temperature, Tm, at which the protein becomes 50% unfolded. The minimum CD 
signal of pure, folded protein (215 nm) was used to monitor the melting process. As the 
temperature was increased, the signal at 215 nm gradually increased and then went through 
a sharp transition between 40 °C and 55 °C before plateauing from 60 °C onward. This 
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signal was converted to percent folded using Eq. (2) and multiplying by a factor of 100, and 
plotted against the temperature (Figure 1.4B). The Tm was found at approximately 50 °C; 
YapG50-512 is a thermally stable construct. After melting to 90 °C, the wavelength spectrum of 
YapG50-512 resembles the canonical random coil signal, confirming that YapG50-512 was 
completely unfolded during the melting process (Figure 1.4A). Cooling back to 10 °C did not 
result in recovery of the pre-melting spectrum. Since thermal denaturation of YapG50-512 is 
not reversible, thermodynamic constants were not calculated. 
 
1.2.4 YapG50-512 Steady-State Unfolding 
Equilibrium unfolding of YapG50-512 was performed with urea and monitored by the 
CD signal at 215 nm. Individual 0.5 µM protein aliquots were denatured in 0.25 M urea steps 
from 0 M urea to 4 M urea and allowed to equilibrate for a minimum of 1 hour before 
wavelength spectra were recorded. As the concentration of urea was increased the signal 
transitioned from a folded, canonical β-helical, signal to an unfolded signal between 1.75 M 
urea and 3 M urea (Figure 1.5A, selected spectra shown of those collected). Plotted as the 
percent unfolded versus concentration of urea as described by Greenfield et al. (34, 35) in 
detail and briefed in Methods (Section 1.4), YapG50-512 undergoes a one-step unfolding 
pathway with transition from folded (F) to unfolded (U) occurring at approximately 2 M urea 
(Figure 1.5B). Using the transition points between F and U, a plot of ∆G versus the 
concentration of urea gives ∆GF, the ∆G of folding, as the y-intercept (Figure 1.5C). Using 
this method the ∆GF of YapG50-512 is -5.53 kcal/mol. 
 In the same manner as the equilibrium unfolding monitored by CD, a measure of the 
secondary structure throughout the unfolding process, YapG50-512’s intrinsic tryptophan 
fluorescence in the presence of increasing concentrations of urea was recorded. YapG50-512 
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has four tryptophan residues within its passenger domain sequence (Figure 1.1: W86, 
W239, W300, and W427, tryptophans are also colored orange in the YapG passenger 
homology model, Figure 1.3). Figure 1.6A shows the non-denaturing emission spectrum of 
YapG50-512 after excitation at 295 nm. As the concentration of urea is increased, the emission 
spectrum peak shows a decrease in intensity and a slight red shift. The change in intensity 
of the peak maxima was used to plot the percent folded versus concentration of urea (Figure 
1.6B). As observed in equilibrium CD measurements, the transition point from folded to 
unfolded was observed at approximately 2 M urea and was a one-step transition. The 
YapG50-512 ∆GF was observed to be -7.24 kcal/mol (Figure 1.6C).  
 
1.2.5 YapG50-512 Stopped-flow Kinetics of Refolding/Unfolding 
Stopped-flow fluorescence experiments were performed to elucidate the kinetics of 
unfolding/refolding YapG50-512. Unfolding was monitored by mixing 5 μM YapG50-512 in 0 M 
urea buffer 1:10 with 4 M urea buffer for a final concentration of 0.5 μM YapG50-512 and 3.6 M 
urea. Here, a signal decrease is associated with the loss of tryptophan fluorescence due to 
a change in the tryptophan(s) environment (from a folded environment to an unfolded 
environment). Figure 1.7A shows a 2 second trace of YapG50-512 unfolding fit with a single 
exponential, 3 parameter fit (Eq. (5)). Residuals for the fit were random (Figure 1.7B), and 
did not require additional exponential terms. Unfolding of YapG50-512 occurs with a rate 
constant of 5.61 s-1. 
Refolding was monitored by mixing 5 μM YapG50-512 in the presence of 4 M urea 1:9 
with 0 M urea buffer (Figure 1.8). Unlike the unfolding process, refolding of YapG50-512 was 
best fit to a two exponential, 5 parameter fit (Eq. (6)), as seen by the improvement in 
residuals upon fitting with a double exponential versus a single exponential (Figure 1.8B, C). 
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Refolding is seen to be a two event process, the first very rapid (< 2 seconds, k1 = 3.8 s-1) 
and the second a slower event (< 10 seconds, k2 = 0.33 s-1). Improvement in the fit was not 
found by adding additional exponential terms. The multi-state behavior of YapG50-512 
refolding led to consideration of possible folding mechanisms including possible 
directionality of folding and whether off pathway aggregation might contribute to wild-type 
refolding kinetics.  
 
1.2.6 Directionality of Folding 
It remains unknown if passenger domains fold directionally, starting the folding 
process on one terminus and folding sequentially toward the other terminus, or if they fold 
by overall globular collapse followed by fine adjustments of tertiary structure. The YapG50-512 
native tryptophan residues (W86, W239, W300 and W427) are spread throughout the 
sequence, one near each terminus, and two in the middle (Figure 1.1), providing the means 
to observe folding in different regions of the sequence via single tryptophan mutants. To 
examine whether the two rates of refolding seen in wild-type YapG50-512 are a result of 
directional folding, tryptophan residues were mutated to phenylalanine, leaving a single 
tryptophan (3 of the 4 tryptophan residues mutated) on either the N-terminus or the C-
terminus (designated WFFF and FFFW) for excitation .  
To verify that mutation of 3 of the 4 tryptophans to phenylalanine did not disrupt the 
stability of YapG50-512, CD wavelength spectra and thermal denaturation data were collected 
(Figure 1.9). The wavelength spectrum of WFFF overlaps with wild-type, and the spectrum 
for FFFW nearly overlaps with wild-type, suggesting the secondary structure is the same in 
the mutants as in wild-type (Figure 1.9A). In addition, thermal denaturation indicated that the 
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mutants were at least as stable as wild-type, with melting temperatures all within a few 
degrees of wild-type (Figure 1.9B). 
Equilibrium fluorescence emission of WFFF and FFFW after excitation at 295 nm 
was used to observe the individual environments of W86 and W427 upon unfolding with 
urea. As the concentration of urea was increased, WFFF was immediately quenched with 
the addition of urea (Figure 1.10A) and FFFW showed no change in emission with the 
addition of urea (Figure 1.10B). The fluorescence intensity observed for FFFW was 
approximately 50% of that for WFFF and the peak was shifted to 330 nm versus 355 nm for 
WFFF. Refolding kinetics of WFFF or FFFW was unable to be recorded due to quenching 
and the lack of change in emission spectra at W86 and W427, respectively. 
Based on the FFFW and WFFF equilibrium and stopped-flow experiments, we 
hypothesized that the two middle tryptophans make up the majority of the wild-type signal. 
To test this hypothesis, FWWF was created. Upon denaturation, FWWF demonstrated 
steady-state fluorescence similar to wild-type in peak maxima shift, but without the overall 
change in amplitude (Figure 1.11A) To observe refolding of FWWF, a 320 nm cutoff filter 
was used, which would display nearly the entire spectrum of the unfolded protein and only a 
fraction of the spectrum for the folded protein (signal decrease upon refolding). FWWF 
refolds very quickly, within 10 seconds. As seen in wild-type, a double exponential, 5 
parameter curve best fits the data, with rates of k1 = 0.33 s-1 and k2 = 3.07 s-1, nearly 
identical to wild-type (Figure 1.11B). Additional exponential terms did not increase the 
quality of the fit or the randomness of the residuals (Figure 1.11C, D). Thus, the overall 
change in environment (folding process) observed in wild-type YapG50-512 (WWWW) is the 
same as that seen with FWWF. 
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1.2.7 Potential for Aggregation during Refolding 
Off pathway aggregation was considered as a possible source of the multi-state 
protein folding seen in YapG50-512. To investigate this possibility, pure YapG50-512 and 
refolded YapG50-512 were run over a gel filtration column. Pure YapG50-512 eluted as a single, 
symmetrical peak, while refolded YapG50-512 eluted in multiple peaks (Figure 1.12). The two 
peaks seen for YapG50-512 straddle the pure YapG50-512 peak. The two peaks are connected 
and elute with the second peak dominant to the first and the first appearing as a shoulder on 
the second peak. Due to the closeness of their elution volume, it is likely that the two 
species are the same size, but are two differently folded populations of YapG50-512. There 
was no peak associated with the void volume of the gel filtration column (approximately 45 
mLs); no aggregation occurs during the refolding process. Concentration limitations 
prevented collection of these peaks and analysis using DLS.  
 
1.2.8 Crystallization Trials 
The YapG50-479 construct, which has a more definitive end in its secondary structural 
prediction versus YapG50-512, was designed primarily for crystallization considerations. Pre-
screening of YapG50-479 was done at multiple concentrations (2mg/mL – 10 mg/mL). Initial 
crystal hits of YapG50-479 were found using the Rigaku high-throughput crystallization 
screening robot at the UNC Biomolecular X-ray Crystallography Facility. Screens utilized 
included pH Clear, Classics Lite, PEGs, and PEGs II (QIAGEN) among others. Initials hits 
found all came from the PEGs screens, and all included 0.2 M lithium sulfate and 0.1 M Tris 
pH 8.5, with varying high percentage PEGS: 30% PEG 3000, 30% PEG 4000, or 25% 
PEG5000. All conditions produced needle-like rods, often growing in stacks. Initial hits were 
optimized using several methods: optimization screens, micro-seeding and macro-seeding, 
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decoupling, additive screens, volume/ratio screens (total volume of drop as well as the ratio 
of protein to mother liquor). 
Crystals of YapG50-479 (Figure 1.13) were found to diffract poorly or not at all.  
Multiple approaches were utilized to encourage YapG crystals to diffract.  The protein 
concentration for crystallization was reduced to eliminate aggregation during concentration 
and crystallization after Dynamic Light Scattering (DLS) indicated that YapG50-479 aggregates 
at concentrations beyond 2.5 mg/mL. Trays were subsequently all set up at 2.5 mg/mL, at 
which DLS indicated a single, monodisperse species (polydispersity < 10%).   
Crystal trays were set up at 4 °C (versus 20 °C) to reduce the likelihood of any 
thermal denaturation during crystallization. Cleavage of the His tag used for purification was 
performed, and found to make a slight difference in crystal morphology but not in diffraction 
quality.             
 Surface entropy reduction (SER) mutations were introduced into YapG50-479 to 
exchange clusters of high entropy amino acids (lysine, glutamic acid, for example), 
predicted to be on the surface of the protein where crystal packing occurs, for alanine.  
Clusters of high entropy amino acids were chosen using the Surface Entropy Reduction 
Prediction Server (36). Three clusters were identified in YapG, numbered SER1-SER3 
based on their score from the server. Clusters were identified in the YapG homology model 
and found to be reasonably placed with respect to the protein surface (Figure 1.14A).  The 
higher the score, the more likely the cluster’s mutagenesis to alanine was predicted to 
contribute to a change in crystal packing and potentially diffraction quality.  The SER2 
cluster (KKQAAA) was on the N-terminus of the wild-type construct and when introduced 
to the sequence, the construct was truncated to begin with the SER2 mutation.  SER1 
(EKKAAA), in the middle of YapG50-479, was also cloned with the SER2 start and was 
therefore termed SER1/2.  SER3 (EKAA) was cloned into the original 50-479 construct.  
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All SER mutations (SER1/2, SER2, and SER3) were overexpressed, refolded, and purified.  
SER mutations were considered properly refolded by comparison to wild-type CD 
wavelength scans (Figure 1.14B).  SER mutations were not found to have any new 
crystallization conditions and did not prove beneficial to crystallization of YapG50-479.   
 
1.3 Discussion and Future Directions 
1.3.1 The YapG50-512 Passenger is a Fast Folding β-helix 
 YapG, a secreted autotransporter from Y. pestis, is unique because of its redundant 
cleavage region and KDEL sequence (Figure 1.1) (19). The homology model built for the 
YapG passenger is strikingly similar to the P.69 pertactin structure (Figure 1.3) (10), and 
while possibly correct, highlights the weakness of homology models without many structural 
templates. However, the current homology model is useful for development of hypotheses in 
the absence of an X-ray crystal structure. Homology modeling combined with multiple 
secondary structural predictions of the YapG passenger domain predict the passenger is 
made up of a β-helical spine beginning with the N-terminus that extends to residue 479, 
followed by an extended region of little to no structural content, including the repeat region, 
to the beginning of the autotransporter domain. The functional region of the YapG 
passenger is presumed to be contained within the minimum cleaved fragment (YapG50-512, 
Chelsea Lane, Ph.D., Miller lab, data not shown). 
YapG50-512 has been found to be entirely β-strand in nature (Figure 1.4A), with no 
apparent α-helical content. CD spectra indicate a canonical β-helical signal, with minima 
around 215 nm. The 50-512 construct was found to be thermally stable, with a Tm of 50 °C. 
CD and intrinsic tryptophan fluorescence equilibrium studies of YapG50-512 display a single 
step, two-state folding (Figures 1.5 and 1.6). The ∆GU calculated from these experiments is 
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within that expected for stable proteins, -3 to -15 kcal/mol (37). Time-resolved kinetics using 
stopped-flow fluorescence, however, suggest a multi-state folding process. 
The most striking result from YapG50-512 refolding kinetics studies was the speed of 
refolding. YapG50-512 was observed to completely refold in vitro within 10 seconds (Figure 
1.9) and without formation of aggregates (Figure 1.13). This result makes YapG50-512 the 
fastest refolding β-helix to date, and 3 orders of magnitude faster than in vitro refolding of 
pertactin (15) and more in line with the predicted rate of refolding based on contact order 
(38). Interestingly, despite the disparity between their in vitro refolding rates, neither YapG50-
512 nor pertactin are observed to form aggregates during refolding. However, like pertactin, 
YapG50-512 exhibits multi-state folding, leading the role of each folding step to be questioned. 
Gel filtration of refolded YapG50-512 suggests that two same size, but slightly different shaped 
protein forms exist in solution (Figure 1.12). It is possible that two differently folded species 
form during refolding, and the folding of each of these two species makes up the multi-state 
behavior seen in in-vitro refolding kinetics. 
Further investigation into the multi-state behavior of YapG refolding includes 
refolding and unfolding YapG50-512 to a variety of final denaturant concentrations to create a 
Chevron plot. If the Chevron plot displays non-linearity it will act as further validation that 
YapG50-512 exhibits multi-state refolding. In addition, insight into the mechanism of refolding 
remains a goal of this research, with the desire to define the folding events associated with 
each of the two defined refolding rates. Current progress toward elucidating the refolding 
mechanism is discussed below.  
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1.3.2 Role of Proline Isomerization 
 For other β-helices, namely the P22 tailspike and pectate lyase C, proline cis/trans 
isomerization has been found to be associated with a second, slower rate constant during 
refolding experiments (16, 32) and in many instances as the rate-limiting step in protein 
folding (39). In this process, the isomerization between the cis and trans form of this amino 
acid’s side chain slow the folding rate of the protein. The rate of prolyl peptide isomerization 
in unstructured peptides is (0.01-0.1s-1) (40, 41).  
The YapG50-512 construct contains eight prolines; without the crystal structure it is not 
possible to know whether any cis prolines exist in the native structure. However, YapG50-512 
refolding (Figure 1.9, k1 = 3.8 s-1 and k2 = 0.33 s-1) is too fast for proline isomerization to be 
the source of either of the rates found in refolding experiments.  
 
1.3.3 Directionality of Folding 
Previous β-helical studies have suggested that some autotransporter passenger 
domains have a stable core in the C-terminus which folds before the N-terminus (7, 14). 
Selective mutation of three of the four tryptophan residues in YapG50-512 to phenylalanine 
allowed for single, C-terminal (W427) or N-terminal (W86), intrinsic tryptophan fluorescence. 
Using this experimental set up, it was expected to be possible to extrapolate whether the 
folding of a stable core on one terminus might represent one of the two refolding rates seen 
in YapG50-512 refolding. Thus, if the YapG passenger contains a C-terminal stable core as 
seen in Pet and pertactin, multi-state refolding would be observed using FFFW and two-
state refolding would be observed with WFFF. CD and thermal denaturation indicated that 
both WFFF and FFFW maintained their secondary structure and stability (Figure 1.10). 
However, steady-state emission spectra after excitation at 295 nm indicated that only the N-
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terminal tryptophan experienced an environmental change upon denaturation with 4M urea 
(Figure 1.11) and this change was very slight. Refolding kinetics of WFFF or FFFW was 
unable to be recorded due to the lack of change in emission spectra at W86 or W427. 
The lack of change in emission maxima and intensity for W86 and W427 suggested 
the environmental change observed by the two internal tryptophans, W239 and W300, upon 
unfolding/refolding are responsible for wild-type emission behavior. Indeed, FWWF was 
observed to undergo a red shift in its emission maxima upon denaturation and its refolding 
kinetics was nearly identical to wild-type. The direction of the refolding was opposite that 
observed in wild-type because FWWF did not undergo a significant intensity decrease upon 
denaturation and a different cutoff filter was used to observe the refolding event (320 nm 
cutoff versus 305 nm), but the fitted rates are nearly identical (FWWF k1 is 19% less than 
WWWW, k2 is identical) to those observed in wild-type. 
An additional method of elucidating whether YapG50-512 folds directionally would be to 
attach a fluorescein molecule on each terminus of the protein, creating an N-terminally and 
a C-terminally fluorescent construct, and measuring their respective refolding kinetics as 
measured for pertactin by Junker and Clark (15). This method would best be designed with 
a crystal structure of YapG so that surface exposed regions could be selected for placement 
of the fluorescein molecules (as done for pertactin). However, despite limitations from the 
lack of a crystal structure for YapG, the fluorescein experiment would be ideal for passenger 
domains like YapG because they do not contain native cysteine residues (thought to be 
associated with the need for passenger domains to remain unfolded until secretion from the 
bacterial outer membrane) and the introduction of a single cysteine would guarantee that 
only one fluorescein molecule would specifically bind to the designed constructs. In the case 
of pertactin, site specific fluoresceine labeling as described above showed that the N-
terminally and C-terminally labeled proteins both refolded at the same rate in vitro, 
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suggesting the passenger domain’s termini fold on similar time scales, rather than one 
terminus folding preferentially before the other (15). 
 
1.3.4 Crystallization of Yaps 
The crystal structure of the YapG passenger domain was sought for use in 
determining its structure-function relationship in combination with functional data from the 
Miller lab at UNC Chapel Hill. The YapG50-479 construct was designed with crystallization in 
mind by stopping the construct before the predicted long, unstructured repeat/cleavage 
region. Crystals were grown in multiple PEG containing conditions but none were found to 
diffract well enough for structure determination using either in-house or synchrotron beam 
sources.  
Future attempts at crystallization could include trials of the YapG50-512 construct. The 
inclusion of a portion of the unstructured region is not likely to improve crystallization, but 
DLS results suggest that at 2.5 mg/mL YapG50-512 is a stable dimer instead of a combination 
of monomer and dimer in solution. A more stable oligomer may improve crystal packing and 
diffraction. In addition, crystallization after the addition of Maltose Binding Protein to one 
terminus of the YapG passenger domain construct, or another small, soluble protein which 
easily crystallizes could be beneficial to crystallization.  
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1.4 Methods 
Homology Modeling  
 The YapG50-717 homology model was built using the HHpred homology detection and 
structure prediction using the HMM-HMM comparison online server (42). The model was 
built using multiple templates chosen by the server; MODELLER (43) was used to build the 
model.  
Cloning, Expression, Refolding and Purification 
 DNA for full length YapG was generously donated by Dr. Virginia Miller. YapG50-512 
was incorporated into the LIC (ligation-independent cloning) vector pMCSG7, which includes 
a hexi-His tag N-terminal to YapG50-512 connected by a tobacco etch virus (TEV) protease 
cleavage site (44). YapG50-512 was transformed into E. coli BL21-CondonPlus(DE3)-RIPL 
competent cells (Stratagene) and grown in Luria broth (LB) supplemented with 50 μg/ml 
ampicillin, chloramphenicol, streptomycin, and 25 μg/ml tetracycline each at 37°C with 
shaking.  Cultures were started from a single colony in 5 mL over 8 hours and used to 
inoculate a 100 mL overnight culture.  The resultant pellet was used to inoculate 6 1 L 
cultures in the presence of above antibiotics and 40 μL antifoam (Sigma-Aldrich) per liter LB.  
Cells were grown at 37°C until OD600 reached 0.9-1.0. Protein expression was induced using 
a 1 mM final concentration of isopropyl β-D-1-thiogalactopyranoside (IPTG) and grown for 
an additional 2 hours at 37°C.  Cells were centrifuged at 4,500 x g for 15 minutes at 4°C and 
stored at -80°C. 
 Individual pellets were thawed for YapG inclusion body isolation, refolding and 
purification.  After thawing for several minutes on ice, a pre-mixed solution of lysis buffer (50 
mM Tris pH 8.0, 200 mM NaCl) plus 1 protease inhibitor tablet (Roche), a pinch of lysozyme 
(MP Biomedicals), 350 μL Triton-X 100 (Alfa-Aesar), and 3 μL benzonase nuclease (Sigma-
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Aldrich) were added to the pellet.  After incubating on ice for several minutes, the pellet was 
resuspended into the pre-mixed lysis solution and then sonnicated using a Branson sonic 
dismembrator at 40% amplitude for 3 minutes using pulses of 0.5 sec with an off time of 1.0 
sec between pulses, and spun at 17,000 rev/min for 1 hour.  After centrifugation, the 
resultant pellet was washed in lysis buffer containing 0.5% Triton-X 100 2 times; the first 
wash included repeating the sonication procedure after resuspension and the remaining 
washes included resuspension with a dounce homogenizer. Two additional washes were 
performed in the absence of Triton-X 100. All washes were followed with 10-12 minute 
spins; after each wash the supernatant was discarded. The resultant inclusion body pellet 
was solubilized in 8 M urea overnight at 4 °C on a rotary shaker. 
 Solubilized inclusion bodies were centrifuged at 5,000 x g for 10 min to remove 
insoluble material, diluted to 1.0 mg/mL in 8 M Urea and dialyzed against 2 L refolding buffer 
(50 mM potassium phosphate pH 8.0, 350 mM NaCl) plus 4 M urea for 8-24 hours, then 
repeated step wise with buffer containing 2 M urea, 1 M urea, 0.5 M urea, 0.1 M urea, and 
lastly buffer A (20 mM potassium phosphate pH 7.4, 500 mM NaCl, 50 mM Imidazole, 20 
mM Urea, 0.02% NaN3). After dialysis into buffer A, refolded protein was passed through a 
0.2 μm filter (Millipore) and loaded onto a HisTrap crude column (GE Healthcare) 
equilibrated with buffer A.  YapG was eluted with buffer B (20 mM potassium phosphate pH 
7.4, 500 mM NaCl, 500 mM Imidazole, 20 mM Gdn-HCl, 0.02% NaN3), pooled and loaded 
onto a 16/60 desalting column (GE Healthcare) equilibrated with buffer C (50 mM Tris pH 
8.8, 150 mM NaCl, 5% glycerol). Protein fractions were collected and concentration 
estimated using A280. TEV protease was added to pooled protein fractions at 3% mass and 
left to dialyze overnight against buffer D (50 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT, 5% 
glycerol) at 4°C. After overnight dialysis, TEV cleaved protein was passed over a crude 
HisTrap column equilibrated with buffer C and collected from the flow-through. Protein was 
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concentrated to minimal volume and passed over a Superdex 200 column (GE Healthcare) 
equilibrated in buffer C. Protein fractions were collected from S200 elution, concentrated to 
approximately 2.5 mg/mL and frozen in 40 μL aliquots at -80°C for storage.  
 Refolding protocol was optimized after trials of different refolding methods, including 
rapid dilution into refolding buffer where the solubilized inclusion bodies in denaturant (8 M 
urea or 6 M Gdn-HCl) were introduced drop-wise at a set rate using a syringe pump into a 
large volume of 0 M denaturant refolding buffer with rapid stirring (final concentration of 
approximately 0.2 mg/mL protein). Setup allowed for drops to be introduced into the 0 M 
denaturant buffer directly next to the stir-bar to allow for the most rapid dilution out of 
denaturant possible. This method was attempted with multiple drop rates and final protein 
concentrations with slower rates (0.5 mL/min) and lower final protein concentrations (0.2 
mg/mL) producing a higher refolding efficiency. The final dilute solution (approximately 1 L, 
depending on the starting concentration of inclusion bodies) was then dialyzed overnight 
against 8 L of 0 M denaturant refolding buffer, for a final urea or Gdn-HCl concentration of at 
least 20 mM (concentrations lower than 20 mM caused protein to crash out). In comparison 
to step-wise dialysis refolding, the rapid dilution protocol was less efficient (Table 1.1) and 
its use was discontinued after the step-wise dialysis method was optimized for a higher 
yield.  
Circular Dichroism 
All circular dichroism experiments were performed on an Applied Photophysics 
Chirascan CD spectrometer (Applied Photophysics, Leatherhead, Surrey, U.K.) in CD buffer 
(10 mM potassium phosphate pH 8.0, 200 mM KF). Individual protein aliquots were 
incubated with urea ranging from 0 M to 4 M in 0.25 M steps. After incubation for a minimum 
of 1 hr, CD spectra were collected of each protein/denaturant mixture. Wavelength scans 
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were recorded at 10°C from 260 to 200 nm in quartz cuvettes (Hellma) with a path length of 
0.1 cm with 50,000 points collected at each 0.5 nm step. CD signal in ellipticity was 
converted to mean residue ellipticity (MRE) using Eq. (1), where θ is ellipticity in 
millidegrees, Mr is the sample molecular weight divided by the number of amino acids, C is 
the sample concentration in grams per liter, and l is the path length in cm. 
                              ሾߠሿ ൌ ሾሺߠ ൈ ܯ௥ ൈ 0.1ሻ/ሺܥ ൈ ݈ሻሿ                                          Eq. (1) 
The change in free energy, ∆G, of denaturation was calculated as described by 
Greenfield (34) by first calculating the fraction folded, Fi, at each denaturant concentration 
using Eq. (2): 
ܨ௜ ൌ ቎ሺሾߠሿ௢௕௦ െ ሾߠሿ௎ሻ ሺሾߠሿி െ ሾߠሿ௎ሻ൘ ቏                      Eq. (2) 
where [θ]obs is the MRE at a given denaturant concentration, and [θ]F and [θ]U are the MRE 
when the protein sample is completely folded and unfolded, respectively. The fraction folded 
is simply converted to the folding constant, KF. 
   ܭி ൌ ܨ௜ ሺ1 െ ܨ௜ሻൗ                                 Eq. (3) 
The change in free energy of folding, ∆GF, is then calculated using Eq. (4), where R is the 
gas constant (1.98 cal/mol) and T is the absolute temperature In Kelvin. 
   ∆ܩி ൌ െܴ݈ܶ݊	ܭி                 Eq. (4) 
 Thermal denaturation was observed by monitoring the CD signal at 215 nm over 
heating from 10 °C to 90 °C using a 1 °C step with a tolerance of 0.2 °C and a 30 second 
hold at each temperature. The CD signal for a given protein sample was converted to 
percent folded at each temperature by first converting to the fraction folded, F, using Eq. (2) 
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where [θ]obs is the CD signal at temperature, T, and [θ]F and [θ]U are as describe above. The 
fraction folded was then converted to percent folded by simply multiplying F by a factor of 
100. The temperature at which the protein sample was 50% unfolded is then set at the Tm of 
the sample, and considered a measure of protein stability. 
Intrinsic Tryptophan Fluorescence 
Steady-state fluorescence scans were performed on a SPEX Fluorolog-3 Research 
T-format Spectrofluorometer at 20 °C in 50 mM KxHyPO4 pH 8.0, 150 mM NaCl. Emission 
scans were collected from 300-400 nm after excitation at 295 nm. Slit widths were set at 1 
mm for excitation and 5 mm for emission.  
Kinetics of refolding/unfolding was measured on a stopped-flow fluorimeter 
(SX.18MV, Applied Photophysics) in the Almeida lab (University of North Carolina at 
Wilmington Department of Chemistry and Biochemistry). The fluorescence signal recorded 
was the intrinsic tryptophan emission after excitation at 295 nm. After mixing 9:1 within the 
stopped-flow the concentration of urea was 0.4 M for refolding and 3.6 M for unfolding, and 
the protein concentration was 0.5 µM. Unfolding kinetics were fit with Eq.(5), a single 
exponential, 3 parameter fit.                         
ݕ ൌ ݕ଴	 ൅ 	ܽ݁ି௕௫                                                        Eq. (5) 
Refolding kinetics were fit with both Eq. (5) and Eq. (6), a double exponential, 5 parameter 
fit. Residuals were compared to determine the best fit in all refolding experiments. 
ݕ ൌ ݕ଴	 ൅ 	ܽ݁ି௕௫ ൅	ܿ݁ିௗ௫                                                 Eq. (6) 
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Dynamic Light Scattering 
 Dynamic light scattering experiments were performed on a Wyatt DynaPro Dynamic 
Light Scattering Plate Reader in 50 mM Tris pH 8.8, 150 mM NaCl, 5% glycerol at room 
temperature (23-25 °C).  
 
1.5 Figure Legends 
Figure 1.1 Schematic of YapG. The YapG full length sequence is made up of a signal 
sequence (ss, pink), an autotransporter domain (green), and a passenger domain (blue). 
The region of the passenger predicted to contain little to no secondary structural elements is 
shown with a dashed line. Constructs used in this study (50-479 and 50-512) are indicated 
with a bar and circled residue numbers. The repeat region within the passenger domain 
(residues 509-640) is shown in orange, with cleavage sites marked (Chelsea Lane, Ph.D., 
Miller lab, data not shown). Locations of tryptophan residues are also marked with Ws and 
their residue number.  
 
Figure 1.2 SignalP output for YapG. The SignalP gram-negative neural network predicts 
YapG to have a signal peptide that is cleaved between Ala49 and Asn50. The S-score is 
associated with the likelihood of a sequence to be involved in a signal peptide. The C-score, 
or cleavage site score, should only increase at the cleavage site. The Y-score is the 
derivative of the C-score combined with the S-score. Generated using SignalP (22, 45). 
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Figure 1.3 Homology model of YapG passenger domain. A. Model of the entire 
passenger domain, with cleavage sites for the Pla surface protease shown in magenta 
spheres and the remainder of the passenger domain in cyan ribbon. Locations of tryptophan 
residues are shown in orange sticks. B. Close up of the 50-479 truncated construct to 
optimize for sequence predicted to contain secondary structure.  
 
Figure 1.4 Thermal denaturation of YapG50-512. A. Wavelength spectra of YapG50-512 after 
purification, before melting, at 20 °C (black, downward triangles) and after thermal 
denaturation to 90 °C (grey circles). B. Percent unfolded versus temperature of YapG50-512. 
The Tm of YapG50-512 is shown as the temperature at which the YapG50-512 is 50% unfolded, 
approximately 50 °C. 
 
Figure 1.5 Equilibrium denaturation of YapG50-512 monitored with circular dichroism. A. 
CD wavelength spectra of YapG50-512 in the presence of selected concentrations of 
denaturant. As the concentration of denaturant (urea) increases, the signal at 215 nm 
associated with β-strand content is lost in favor or a more random coil signal. B. YapG50-512 
percent unfolded versus concentration of urea goes through a single transition, indicating 
two-state folding behavior. C. Change in free energy, ∆G (kcal/mol), versus concentration of 
urea for the transition region of YapG50-512 equilibrium unfolding fit with linear regression and 
extrapolated to the axes to determine the ∆G of folding. Points from B used in C are color 
matched for clarity. 
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Figure 1.6 Equilibrium denaturation of YapG50-512 monitored with intrinsic tryptophan 
fluorescence. A. Equilibrium intrinsic tryptophan fluorescence emission spectra of YapG50-
512 in the presence of varying concentrations of urea after excitation at 295 nm. B. Percent 
unfolded YapG50-512 at 350 nm versus concentration of urea. The transition from folded to 
unfolded is colored to indicate the points used in C. ∆G in kcal/mol versus concentration of 
urea. Transition fit to a linear regression and extrapolated to the axes to determine the ∆G of 
folding.    
 
Figure 1.7 Stopped-flow unfolding of YapG50-512. YapG in vitro unfolding is very fast and 
single exponential. A. Unfolding kinetics shown as a function of intrinsic tryptophan 
fluorescence emission after excitation at 295 nm. Experimental data (open circles) fit with a 
single exponential function (black line). B. Random residuals are shown for data fit to a 
single exponential function.  
 
Figure 1.8 Stopped-flow refolding of YapG50-512. YapG50-512 is the fastest in vitro refolding 
passenger domain to date. A. Refolding kinetics is shown as a function of intrinsic 
tryptophan fluorescence emission after excitation at 295 nm. Experimental data (open 
circles) are fit with a single exponential fit (red line) and a double exponential fit (black line) 
B. Random residuals are shown for data fit to a double exponential function. C. Non-random 
residuals are shown for data fit to a single exponential function.  
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Figure 1.9 Comparison of W mutants to wild-type YapG50-512. Mutation to exclude 3 of 
the 4 tryptophans does not interfere with the overall secondary structure (A) or the thermal 
stability (B) of YapG50-512.  
 
Figure 1.10 Intrinsic fluorescence of WFFF and FFFW. Steady-state intrinsic tryptophan 
fluorescence emission after excitation at 295 nm of WFFF (A) and FFFW (B) in non-
denaturing conditions (black) and in the presence of 4 M urea (red). 
 
Figure 1.11 FWWF monitors the same process as wild-type. A. Steady-state intrinsic 
tryptophan fluorescence emission after excitation at 295 nm of FWWF in non-denaturing 
conditions (black) and in the presence of 4 M urea (red). B. Kinetics of refolding is shown as 
a function of intrinsic tryptophan fluorescence emission. Experimental data (open circles) is 
shown fit to a single exponential fit (red line) and a double exponential fit (black line). 
Random residuals are plotted for the double exponential fit (C) and non-random residuals 
are plotted for the single exponential fit (D). 
 
Figure 1.12 Refolded YapG50-512 does not induce aggregation. Overlaid elution profiles 
from gel filtration of purified protein (solid line) with purified protein that was first denatured 
in 6 M urea and then refolded by quick dilution to 0.6 M urea (dashed line) to mimic 
conditions inside the stopped-flow cuvette. No peak is observed in the void volume of the 
gel filtration column where soluble aggregate would be expected to elute. A peak with a 
shoulder of the refolded sample may indicate two differently folded species, likely of the 
same size but of slightly different shapes. 
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Figure 1.13 Crystals of YapG50-479. Best crystals grown during YapG50-479 crystallization 
optimization. Morphologies included rods of approximately 10 x 10 x 200 microns (left), 
plates, and approximately 10 x 40 x 80 trapezoidal shaped (right) crystals. Conditions 
detailed in Methods. 
 
Figure 1.14 Surface entropy reduction mutations introduced into YapG50-479.  A. 
Clusters of amino acids (shown on the YapG50-479 homology model) chosen for mutation to 
alanine in order to reduce surface entropy and potentially aid in crystallization of YapG50-479 
are boxed with their respective scores from the Surface Entropy Reduction Prediction 
Server. B. CD wavelength spectra of SER mutations versus the wild-type YapG50-479 signal. 
Mutations were not found to affect the nature of YapG’s secondary structure. 
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Refolding Protocol
Rapid Dilution Step‐wise Dialysis
Starting culture volume 1.5 L 1.5 L
Starting mass inclusion body 200 mg 200 mg
Days refolding requires 1 > 3
Yield after affinity 5‐8 mg 30‐40 mg
Yield after final purification 0.5‐3 mg 4‐15 mg
Table 1.1 Refolding Protocol Comparison 
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CHAPTER 2 
 
Crystal Structure of the Plant Epigenetic Protein Arginine Methyltransferase 10 
 
 
 
2.1 INTRODUCTION 
 
Protein arginine methyltransferases (PRMTs) catalyze the transfer of methyl groups 
from S-adenosylmethionine (SAM) to arginine residues of target proteins, and release S-
adenosylhomocysteine (SAH) as a product (1). The post-translational methylation of 
arginines is observed widely in eukaryotes and plays essential roles in many biological 
processes, such as signal transduction, chromatin remodeling, RNA processing, gene 
transcription, DNA repair and cellular transport (1-8). PRMTs are generally classified as type 
I or type II (1). Both types catalyze the production of ω-NG-monomethylarginine, but they 
generate distinct dimethyl arginine derivatives. Type I enzymes (e.g., PRMT1, 3, 4, 6, 8) 
specifically produce asymmetric ω-NG,N’G-dimethylarginine, while type II enzymes (e.g., 
PRMT5, 7 and FBXO11) only produce symmetric dimethylarginine (9). The dysfunctions of 
mammalian PRMTs have been correlated with the development of cancer as well as 
autoimmune, cardiovascular, pulmonary and neuro-developmental diseases (10-16).  
While PRMTs have a relatively conserved catalytic core, the portions of each  
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enzyme N-terminal to the catalytic core (the “N-terminal additions”) are divergent in 
sequence and have been demonstrated to be important for the substrate specificity. For 
example, the zinc-finger domain within the N-terminal addition of PRMT3 is essential for its 
recognition of RNA-associated targets (17). Previous structural studies have shown that the 
PRMT catalytic core is composed of three domains: an N-terminal SAM binding domain, a 
central arm domain, and a C-terminal β-barrel domain (18). The main substrate binding site 
is located in a cleft formed between the SAM binding domain and the β-barrel domain (19, 
20). Dimerization is a conserved feature in PRMTs and has been established to be essential 
for the methyltransferase activity of PRMTs (19, 20) by facilitating SAM binding (20).  
PRMT methyltransferase activity is regulated by several characteristics of the target 
protein. For example, the local sequence of the methylation site is an important determinant 
of arginine methylation (21, 22). PRMT-catalyzed reactions typically occur within glycine- 
and arginine-rich motifs, such as “RG”, “RGG” and “RXR” (23), although exceptions have 
been noted (22). The activity of PRMTs can also be affected by the sequences distal to the 
methylation site (24) and by protein binding partners (25, 26). Circumstantial evidence has 
suggested that PRMTs often form complexes with other proteins in vivo, and that these 
proteins impact subcellular location and substrate recognition (27, 28). 
AtPRMT10 is a plant-specific type I PRMT that plays an essential role in the 
regulation of flowering time in Arabidopsis (29). Genetic disruption of AtPRMT10 causes 
delayed flowering due to up-regulated transcription of a major flowering repressor, 
FLOWERING LOCUS C (FLC) (29). Biochemical studies showed that AtPRMT10 can 
specifically methylate arginine-3 of both histone H4 and histone H2A in vitro, and 
preferentially produces asymmetrical dimethylarginines. Besides AtPRMT10, eight other 
AtPRMTs have been identified in the Arabidopsis genome, including AtPRMT1a, 
AtPRMT1b, AtPRMT3, AtPRMT4a, AtPRMT4b, AtPRMT5, AtPRMT6 and AtPRMT7. These 
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AtPRMT paralogs likely have diverse properties in cellular location, substrate specificity and 
protein-protein interaction (1, 7).  
Here we report the crystal structure of AtPRMT10 in complex with a product of its 
enzymatic reaction, SAH. This structure provides insights into how AtPRMT10 interacts with 
peptides, and reveals structural features that may confer unique substrate specificity to 
AtPRMT10, including the role of the AtPRMT10 N-terminal addition in the enzyme function. 
Our studies also show that AtPRMT10 exists predominantly in a dimeric state in solution, 
and disruption of dimerization causes loss of activity. We further examine the impact 
AtPRMT10 dimerization has on enzyme motion using molecular dynamics (MD) simulations. 
Our results highlight distinct differences between AtPRMT10 and other structurally-
characterized PRMTs, but also indicate that motions are a conserved element of PRMT 
function.  
 
2.2 RESULTS 
 
2.2.1 Crystal Structure of the AtPRMT10-SAH Complex 
The structure of AtPRMT10 (residues 11-383) in complex with SAH was determined 
by molecular replacement and refined to 2.6 Å resolution (Table 2.1). The crystal specimen 
employed to solve the structure contained nearly 50% pseudomerohedral twinning as 
indicated by the L-test and Britton plot carried out by the program PHENIX (30). Notably, the 
β angle (89.98o) of the unit cell was very close to 90o. Consequently, the diffraction data 
could also be reduced into the orthorhombic space group P222 and its derivatives. Serious 
violations of systematic absences were observed, however, in space groups P212121, 
P21212, P2221. Consequently, molecular replacement was performed in the space group 
P222. As predicted by the Matthews coefficient, two monomers were identified in each 
asymmetric unit. All solutions in space group P222, however, were finally rejected owing to 
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the presence of significant main-chain clashes during crystal packing. Taken together, these 
results indicated that P21 was the correct space group and pesudomerohedral twinning was 
present. The data were detwinned using the twining refinement function of the program 
PHENIX (30).  No violations in systematic absences for P21 and no clashes between protein 
monomers with four AtPRMT10-SAH complexes per asymmetric unit were observed; the 
structure was determined and refined with good geometry and statistics in this space group 
(Table 2.1). The N-terminal twenty residues of the AtPRMT10 construct employed (residues 
11-30) lack electron density and were not placed in the final refined model. 
AtPRMT10 exhibits three sequentially folded domains: an N-terminal SAM binding 
domain (residue 31-174), a central arm domain (residues 187-236), and a C-terminal β-
barrel domain (residues 175-186 and residues 237-383) (Figure 2.1a, b). The SAM binding 
domain is composed of two N-terminal helices (αX & αY, residues 31-50) followed by a 
classical Rossman fold (residues 51-174) consisting of five α helices (αZ, αZ’, αA, αB, αD) 
and five β strands (β1 to β5). The consensus Rossman fold has been observed in other 
known SAM-dependent methyltransferases (31, 32), while the two N-terminal helices (αX & 
αY) are unique to PRMTs (19). The β-barrel domain, forming close contacts with the SAM-
binding domain at one end of its barrel, harbors ten β-strands (β6 to β15) and two short α-
helices (αH and αI). The arm domain, exhibiting a helix-turn-helix fold, is inserted in between 
β6 and β7 of the β-barrel domain and protrudes from the main body of the protein. 
Sequence analysis reveals four PRMT signature motifs in AtPRMT10 (Figure 2.2). Motif I 
(YFxxY) and Motif II (DVGxGxG) are directly involved in the binding of cofactor SAM. Motif 
III (SExMGxxLxxExM), harbors two critical catalytic residues E143 and E152. Mutation of 
either of these two residues completely disrupted the methyltransferase activity of 
AtPRMT10 (data not shown). Motif IV (or the THW motif) is the most highly conserved 
sequence among PRMTs and is directly involved in the formation of the active site. As 
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expected, disruption of motif IV is accompanied with complete loss of the methyltransferase 
activity of AtPRMT10 (data not shown).  
The structure of AtPRMT10 exhibits a similar overall fold relative to other PRMTs of 
known structure, exhibiting, for example, a 1.8 Å root-mean-square deviation over 245 Cα 
positions with PRMT1 (residues 41-354). However, a strikingly unique feature of AtPRMT10 
is its dimerization arm, consisting of two straight anti-parallel α-helices, which is significantly 
longer (41 Å) than that of other PRMTs (e.g., PRMT1, 22 Å; PRMT3, 22 Å; CARM1, 34 Å) 
(Figure 2.1c). AtPRMT10 also differs from other PRMTs in two loop regions of the β-barrel 
domain (Figure 2.1c). Sequence alignment indicates that these loops are relatively 
conserved among AtPRMT10 orthologs (Supplemental Figure 2.1), but highly divergent 
among PRMT paralogs (Figure 2.2). Loop I is located adjacent to a conserved substrate 
binding site of PRMTs (see below). Acidic residues in Loop II have been shown to be 
important for the interaction of PRMT1 with its substrates (33).  
 
2.2.2 AtPRMT10 Active Site  
In the AtPRMT10-SAH complex, SAH binds within a deep pocket formed by the 
three N-terminal α-helices (αX, αY and αZ) and the carboxyl ends of the parallel β-strands 
(β1 to β5) (Figure 2.1d). Most of the residues involved in SAH binding are highly conserved 
among type I PRMTs (Figure 2.2), indicating that members of the type I PRMT family likely 
share similar mechanisms in cofactor binding and catalysis. Hydrogen bonding plays a 
major role in the interaction of AtPRMT10 with SAH, with six such interactions formed 
between AtPRMT10 and the three moieties of SAH (adenine, ribose and homocysteine). 
R54 of the helix αZ forms bifurcated hydrogen bonds with the terminal carboxylate group of 
the homocysteine moiety. For the ribose moiety, hydrogen bonds are observed between the 
two main-chain hydroxyl groups and the side chains of E100 of strand β2 and Q45 of helix 
αY. The adenine group is recognized by the E129 from the loop between β2 and β4. In 
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addition to hydrogen bonding, the main-chain of the glycine rich loop (G78 and G80) and the 
side-chains of seven other residues (A101, V128, F36, M154, S157, Y35 and Y39) form van 
der Waals contacts with SAH. Given the small difference between the chemical structure of 
SAM and SAH, it is expected that SAM binds to the active site in a manner similar to that 
observed here for SAH. 
 
2.2.3 AtPRMT10 Dimer  
AtPRMT10 forms a ring-like homodimer through the interaction between the 
dimerization arm (αE-loop-αG) of one monomer and the outer surface (αY, αZ, αA & αD) of 
the SAM binding domain of the other monomer (Figures 2.3a, b). Both active sites are 
located at the periphery of the central cavity formed upon dimerization of AtPRMT10. As 
observed for other PRMTs, hydrophobic interactions are a major force during the formation 
of the AtPRMT10 dimer. A network of three hydrogen bonds is also observed at the PRMT 
dimer interface, with the side-chains of Q90 and N115 forming hydrogen bonds with the 
main-chains of G215 and D217 respectively (Figure 2.3c). The hydrogen bonds between 
N115 and D217 are highly conserved among PRMTs (Figure 2.2). Another conserved 
residue at the dimer interface is G215, whose small side-chain is apparently favorable for 
the formation of the sharp turn at the tip of the dimerization arm. Overall, the residues on the 
surface of the SAM binding domain that produce the AtPRMT10 dimer interface are highly 
conserved when compared to other PRMTs.  In contrast, however, the residues that form 
the dimerization arm of AtPRMT10 exhibit little or no conservation with homologous 
enzymes (Figure 2.2 and Supplemental Figure 2.2). 
Notably, due to PRMT’s longer dimerization arm, its central cavity is significantly 
larger than those of other PRMTs with known structure (Figure 2.4).  AtPRMT10 creates a 
cavity 15 Å high by 13 Å wide (15 x 13 Å), while those of PRMT1, PRMT3 and CARM1 
exhibit cavities that are 8x12, 8x13 and 8x11 Å, respectively (Figure 2.4).  The longer 
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“vertical” distance as depicted in Figure 2.4 is generated by the longer AtPRMT10 
dimerization arm. Consistent with the dimer observed in the crystal structure, our results 
from dynamic light scattering and gel filtration experiments confirmed that AtPRMT10 exists 
predominately as dimer in solution, and that the oligomeric state of the enzyme is 
independent of SAH binding (Table 2.2).  
To test the importance of the dimer interface observed in the crystal structure during 
AtPRMT10 function we designed an arm mutant, ∆203-225, in which the part of the 
dimerization arm that forms the dimer interface was replaced with a stretch of glycine and 
serine residues (GGSGGS). AtPRMT10 ∆203-225 was stably over-expressed in E.coli, 
suggesting that it was well folded. The oligomeric state of AtPRMT10 ∆203-225 was 
examined using dynamic light scattering and gel filtration experiments (Table 2.2). Our 
results show that mutation of the dimerization arm disrupted dimer formation. The impact of 
dimerization on the methyltransferase activity of AtPRMT10 was examined by measuring the 
activity of the arm mutant ∆203-225. The arm mutant displayed no observable activity 
toward H2A and H4 (Figure 2.5a, b), indicating that dimerization is essential for the 
methyltransferase activity of AtPRMT10.  
 
2.2.4 AtPRMT10 Surface Electrostatics 
Surface charge distribution appears to impact the function of PRMTs. For example, 
published data have suggested that surface charges are crucial for the interaction of PRMT 
with substrates and other proteins (19, 20). Figure 2.6 illustrates the surface charge 
distribution of AtPRMT10. As seen in other PRMTs, the surface of AtPRMT10 contains 
numerous acidic patches, especially around the active site. However, there are notable 
differences in the surface charge distribution of AtPRMT10 compared to other PRMTs of 
known structure (Figure 2.6). In particular, the unusually long dimerization arm of AtPRMT10 
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contains ten acidic residues (E190, D195, D197, D202, D208, E209, D217, E227, E228, 
E230) (Figure 2.6) that generate a relatively large acidic surface along this domain relative 
to other PRMTs. A second difference is observed at one end of the β-barrel domain, where 
AtPRMT10 has a large acidic patch formed by residues E281, E336, E337, D339, E367 and 
E374 (Figure 2.6). Other PRMTs contain fewer acidic residues in this region (Figure 2.2). 
Acidic amino acid residues in this location have been shown to be important for the 
substrate interaction of PRMT1 (33).  
Structural studies of PRMT1 have indicated the location of the substrate binding groove 
of this enzyme (20). Based on the location of acidic patches and the shape of the 
AtPRMT10 surface in light of other PRMTs of known structure, we have identified four 
putative substrate binding grooves on the surface of AtPRMT10 (Figure 2.6). Binding 
grooves I and II are located in the cleft formed between the SAM binding domain and the β-
barrel domain and are directly connected to the active site. Binding grooves III and IV lie on 
the surface of the β-barrel domain. Substrates can also enter the active site through binding 
groove III. A high degree of conservation is maintained in the residues that form binding 
grooves I and II (Figure 2.6 and Supplemental Figure 2.2), suggesting the conserved role for 
these two binding grooves during substrate interaction. In contrast, little conservation is 
observed for the residues that form binding grooves III and IV (Figure 2.6 and Supplemental 
Figure 2.2). It is possible that the unique compositions of binding grooves III and IV may 
confer unique substrate specificities upon AtPRMT10 compared to other PRMTs. 
 
 2.2.5 Increased Active Site Accessibility in AtPRMT10 
While the PRMT family shares a three-domain architecture and a dimeric 
oligomerization state, the relative orientation of the two monomers in a functional dimer 
significantly varies between different PRMTs due to the diversity in dimerization arm length 
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and composition. Consequently, the dimeric forms of different PRMTs do not superimpose 
well. When we align different PRMTs based on one of their two monomers (the “bottom 
monomers” in Figure 2.7a, left panel), the other monomers (the “top monomers”) are 
translated to distinct locations. In Figure 7a (left panel), the top monomers of PRMT1 (cyan) 
and PRMT3 (yellow) are located directly above their bottom monomers, while the top 
monomers of AtPRMT10 (magenta) and CARM1 (blue) are positioned away from the 
vertical by 30o and 20o, respectively. The top monomers of AtPRMT10 and CARM1 are also 
observed to be translated leftward 21 Å and 13 Å to the left, respectively, relative to the 
position of PRMT1 and PRMT3 (Figure 2.7a, middle panel). Finally, the angles formed by 
the two monomers of a PRMT dimer vary significantly among enzyme paralogs, ranging 
from 30o in PRMT3 to 52o in AtPRMT10 (shown schematically in Figure 2.7a, right panel).  
The differences in the relative orientation of the two monomers in PRMT dimers, 
together with the differences in the size of the central enzyme cavities, result in significant 
variations in active site accessibility across the enzymes of known structure. To provide a 
quantitative measure of active sites accessibility for different PRMTs, we determined an 
accessibility angle for AtPRMT10, CARM1, PRMT1 and PRMT3. With the bottom monomers 
in the same orientation, a vertex was placed in the center of dimer cavity, and from that 
point the largest angle allowed by the molecular surface of the dimer in two dimensions in 
this view was traced for each structure (Figures 2.7b-7e).  For AtPRMT10, the accessibility 
angle was ~120° (Figure 2.7b). However, for PRMT1 and PRMT3 and CARM1, the 
accessibility angles were ~50°, ~45°, and ~20°, respectively (Figures 2.7c-7e). Thus, the 
unique size and orientation of the AtPRMT10 central cavity creates a significantly larger 
accessibility to this enzyme’s active site relative to the PRMTs of currently known structure.  
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2.2.6 AtPRMT10 Motion 
Because dimerization has been shown to be essential for the methyltransferase 
activity of PRMTs, we examined the impact dimerization has on the motion of AtPRMT10 
using 30 ns molecular dynamics (MD) simulations. Monomeric and dimeric forms of 
AtPRMT10 were examined. The total energy of each system, calculated as the sum of the 
kinetic and potential energy at each time point, was relatively constant after the first 5 ns, 
particularly over the last 10 ns (Figure 2.8). Therefore, the averages of the MD trajectories in 
the last 10 ns were used for the following analysis. The effect of dimerization on the degree 
of motion of AtPRMT10 was determined by computing the atomic position fluctuations 
(APFs) of Cα atoms of the monomer and dimer form. Overall, AtPRMT10 exhibits similar 
APFs in monomeric and dimeric states; however, in the dimeric form, two regions (αY-loop-
αZ, residues 40-68; the dimerization arm, residues 187-235) displayed significantly lower 
APFs than when in the monomeric form (Figures 2.9a, b). The reduced fluctuations within 
these two regions likely result from their direct involvement in the formation of the dimer 
interface (Figure 2.3C). Notably, the region αY-loop-αZ (residues 40-68) is directly involved 
in the binding of SAH and in the formation of substrate binding groove I. Therefore, 
stabilization of this region by dimerization likely improves the binding of SAH and substrate 
proteins.   
We computed normalized covariance matrices to classify the motions of all residue pairs in 
the protein (Figures 2.9c, d). Normalized covariance matrices generate the residue-residue 
correlation coefficients (Cijs), which inform the relative motion between a residual pair. 
Based on the value of Cijs, the motions of all residue pairs can be classified into three 
groups: correlated motion (two residues moving toward the same direction) as indicated by 
Cij approaching 1, anti-correlated motion (two residues moving toward the opposite 
direction) as indicated by Cij approaching -1, and uncorrelated motion (two residues moving 
with the lack of a dynamic relationship) with Cij values near zero. The SAM binding domain 
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of dimeric AtPRMT10 exhibits considerably greater residue-residue correlations relative to 
that of monomeric AtPRMT10 (Figure 2.9c). Increased residue-residue correlations are also 
observed in several discrete regions of the β-barrel domain.   
To better understand the biological significance of residue-residue correlations, single-
linkage clustering analysis was then conducted to identify groups of residues that move 
together. Clustering of dimeric AtPRMT10 at a correlation coefficient above 0.7 resulted in 
five clusters, while clustering of monomeric AtPRMT10 under the same criterion only 
resulted in three clusters (Figures 2.9e, f). One notable difference between monomeric 
AtPRMT10 and dimeric AtPRMT10 lies in the SAM binding domain. Most of this region, 
except the two N-terminal helices (αX and αY) and two loop regions (L1 and L2), are 
clustered in dimeric AtPRMT10 (Figure 2.9g), while only helix B is self-clustered in 
monomeric AtPRMT10. In addition, one end of the β-barrel domain is clustered in dimeric 
AtPRMT10, but not in monomer AtPRMT10. These data establish that the SAM binding 
domain and one end of the β-barrel domain to move as a cohesive unit in dimeric 
AtPRMT10, but not in monomeric AtPRMT10.  
To extend these investigations into other PRMTs, we examined the motion of monomeric 
and dimeric PRMT3 using the same MD simulation protocol described above. Similar to 
AtPRMT10, dimerization significantly lowered the APFs in the N-terminal region (αX-αY-αZ, 
residues 208-245) and the dimerization arm (residues 370-394) (Supplemental Figure 2.3a). 
In addition, normalized covariance analysis clearly shows that dimerization promotes 
coherent protein motions in the SAM binding domain and several discrete regions of the β-
barrel domain (Supplemental Figure 2.3b, c). Taken together, our results show that 
dimerization productively impacts the motion of the PRMTs.  In particular, the SAM binding 
domain in both AtPRMT10 and PRMT3 move as a cohesive unit in the enzyme dimer but 
not the monomer. 
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2.2.7 PRMT10 N-terminus in Enzyme Function  
Finally, we examined the impact of the N-terminal addition (residues 1-30) on the 
dimeric state and methyltransferase activity of AtPRMT10. We created three N-terminal 
deletion mutants, including ∆N10 (residues 11-383), ∆N20 (residues 21-383) and ∆N30 
(residues 31-383), and compared their biophysical properties and methyltransferase 
activities to those of full-length AtPRMT10. The oligomeric states of these mutants were 
investigated using dynamic light scattering (DLS) and gel filtration experiments (Table 2.2). 
As observed in the wild-type enzyme, all N-terminal deletion mutants form dimers in 
solution. Moreover, the oligomeric states of these mutants are SAH-independent. Together, 
these data suggest that the N-terminal addition does not impact AtPRMT10 dimerization.    
The methyltransferase activities of wild-type AtPRMT10 and the three N-terminal 
deletion mutants were measured as described previously (29); while these initial studies do 
not provide kinetic values, they are sufficient to highlight relative differences in enzyme 
function (Figure 2.5a, b).  Purified calf thymus core histones, which are a mixture of histones 
H2A, H2B, H3 and H4, were chosen as the substrate. Of these four histones, H2A and H4 
are known to be methylated by AtPRMT10. Upon analysis of the experiment by SDS-PAGE, 
the methylation state of H2A and H4 can be quantified individually, due to their difference in 
molecular weight. Interestingly, ∆N10 had approximately 3-fold greater activities toward H2A 
relative to the wild-type enzyme. Additional deletions of the N-terminus (∆N20 and ∆N30) did 
not enhance the methylation of H2A by AtPRMT10. When H4 was used as the substrate, 
however, all three N-terminus mutants displayed wild-type level activities (Figure 2.5a, b). 
These results indicate that first ten residues of AtPRMT10 impact enzyme methyltransferase 
activity in a protein substrate-dependent manner. In the AtPRMT10 crystal structure, the 
helix αX (residues 32-40) covers the opening of the SAM binding pocket and stabilizes SAH 
binding with van der Waals interactions (Figure 2.1). As expected, the deletion of helix αX 
(∆40) causes a dramatic drop in the activity for both H2A and H4.  
60 
 
Previous studies of PRMT1 have shown that amino acids distal to the methylation 
site can affect the methylation of H4 (24).  Thus, we examined whether the substrate 
sequence outside of the methylation site also impacts the activity of AtPRMT10. We 
examined the purified full-length histone H4 as well as H4N1-20, a peptide covering only the 
N-terminal twenty residues of histone H4. We found that the activity of AtPRMT10 on the 
full-length H4 substrate was markedly higher than that on the H4N1-20 substrate (Figure 
2.5c), in spite of a 10-fold higher concentration of H4N1-20 was present in these assays. 
Thus, it appeared that the sequence downstream of the N-terminal 20 residues of histone 
H4 enhanced the methyltransferase activity of AtPRMT10.  
The methylation site of AtPRMT10 in both histone H2A and histone H4 is located at 
the far N-terminus of these proteins. To examine whether a bulky protein fused to the N-
terminus of H4 would impact AtPRMT10 activity at arginine-3 on H4, we compared the 
methylation of histone H4 and N-terminally GST-tagged histone H4 (GST-H4) by AtPRMT10 
(Figure 2.5c). Our results show that the presence of a N-terminal GST tag modestly reduced 
the activity of AtPRMT10 by ~2-fold relative to untagged H4. These data indicate that 
AtPRMT10 can methylate R3 of H4 even when it is not located at the far N-terminus of this 
histone protein.  
 
2.3 DISCUSSION 
We present the first structure of a plant protein arginine methyltransferase, that of 
AtPRMT10, and highlight unique features of this enzyme, including a long dimerization arm 
and a distinctly open conformation in the catalytic dimer.  We also establish for the first time 
that the family of PRMTs exhibit conserved domain motions, particularly within the enzyme 
region that binds the SAM cofactor that donates the methyl group to arginines on target 
proteins. Together, these data advance our understanding of features shared by the PRMT 
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enzymes, which function as both epigenetic and non-epigenetic factors, as well as unique 
aspects particular family members may employ to impact substrate preference. 
In a functional PRMT dimer, the enzyme active sites are located at the periphery of a 
central cavity (Figure 2.3). This configuration likely impacts access of substrate proteins to 
the PRMT catalytic site. Indeed, most known methylation sites are located in disordered 
regions of substrates, and the structural flexibility around the methylation site has been 
shown to be essential for PRMT function (22). Comparing PRMT dimers of known structure 
demonstrates that PRMT paralogs exhibit a range of accessibility in the active site, which 
can be roughly summarized as: AtPRMT10>PRMT1>PRMT3>CARM1 (Figure 2.7). These 
variations result primarily from differences in the relative orientation of the two monomers in 
a functional PRMT dimer and differences in the dimerization arm length. Previous studies 
have suggested that the activity and substrate specificity of PRMTs are directly correlated 
with active site accessibility (34). Thus, it is possible that the more accessible AtPRMT10 
active site may allow this enzyme to methylate arginine residues that do not serve as 
substrates for other PRMTs.  
We show that AtPRMT10, like other PRMTs, functions only as a dimer (Figure 2.5). 
MD simulations on both the monomeric and dimeric forms of AtPRMT10 and PRMT3 show 
that dimer formation produces coherent motions in key catalytic domains (Figure 2.9 and 
Supplemental Figure 2.3). PRMT dimers exhibit reduced fluctuations in the N-terminal αY-
loop-αZ region, which not only forms direct contacts with the SAM methyl donor, but also 
forms a portion of substrate binding groove I that is conserved among PRMTs. Furthermore, 
dimerization results in more correlated motions throughout the SAM binding domain. 
Previous studies have shown that oligomerization can facilitate protein-ligand interaction by 
increasing the correlation in the motion of the structural elements involved in ligand binding 
(35). Importantly, our results show that the effects of dimerization on the motion of 
AtPRMT10 can be generalized into other members of the PRMT family (Supplemental 
62 
 
Figure 2.3). Dimerization appears to facilitate the methyltransferase activity of PRMTs by 
producing coherent protein motions in the SAM binding region.  
Members of the PRMT family have a relatively conserved catalytic core, but exhibit 
remarkable diversity in the length and sequence of their N-terminal regions. Multiple lines of 
evidence suggest that the variations in the N-terminus diversify the functions of the PRMT 
family by modulating the substrate specificities (17, 36-38). AtPRMT10 has a 30-residue N-
terminal addition, which is one of the shortest among known PRMTs. Secondary structure 
analysis predicts that the N-terminal addition of AtPRMT10 remains in a disordered state. In 
support of this prediction, the AtPRMT10 N-terminal addition is prone to proteolysis (data 
not shown), and is not ordered in our crystal structure. Although PRMT1 also has a short N-
terminal region (~30 residues), its length varies more among different PRMT1 isoforms and 
these variations have been shown to alter the substrate specificity of PRMT1 (39).  
The results presented here indicate that residues 1-10 can affect the substrate 
specificity of AtPRMT10 (Figure 2.5a, b). The deletion of the N-terminal addition enhances 
the activity of AtPRMT10 toward histone H2A, but does not significantly alter AtPRMT10 
activity toward histone H4. This variation may result from the difference in the way that H4 
and H2A interact with AtPRMT10.  Based on the crystal structure of dimeric AtPRMT10, the 
30-residue N-terminal addition is likely located at one side of the ring, adjacent to substrate 
binding grooves III and IV, but distant from substrate binding grooves I and II. Thus, H2A 
may employ AtPRMT10 substrate binding groove III or IV, while H4 employs substrate 
binding groove I. The local sequence of the methylation site in H2A (SGR3GKGG) is 
identical to that of H4 (SGR3GKGG), indicating that the sequence outside the methylation 
site is also important for the interaction of PRMT with its substrates. In support of this notion, 
our results demonstrate that deletion of the sequence C-terminal to residue 20 of H4 
dramatically reduced the methylation at arginine 3 by AtPRMT10 (Figure 2.5c).   
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PRMT10 displayed comparable activities toward histone H4 and N-terminally GST-
tagged histone H4 (GST-H4) (Figure 2.5c). In histone H4, the methylation site arginine-3 is 
located proximal to the N-terminus. Therefore, the standard H4 substrate can bind to the 
AtPRMT10 binding grooves in a linear fashion, as modeled in the crystal structure of 
PRMT1-peptide complex (20). Our results with the GST-H4 substrate, however, indicate that 
the target arginine of AtPRMT10 could be located internally within a larger protein, rather 
than only within an N-terminal tail. Such an observation expands the scope of potential 
substrates for AtPRMT10 to include proteins with target arginines located on flexible central 
loops capable of accessing the AtPRMT10 active site.  Such substrate proteins may be 
identified in Arabidopsis that impact flowering time in a AtPRMT10-dependent manner.  In 
summary, the data presented here indicate that, while the PRMTs share some key traits 
(e.g., a functional dimer and coherent SAM-binding domain motion), unique features of 
specific PRMTs, like the larger central cavity of the AtPRMT10 dimer, may lead to unique 
methylation patterns and target substrate proteins.  
 
2.4 METHODS 
Cloning, expression and purification of AtPRMT10 
The expression plasmids encoding wild-type AtPRMT10 (1-383) and its various 
mutants and related constructs were created using the standard ligation-independent 
cloning techniques, as described by Stols et al. (40). All expression plasmids used in this 
study were sequence verified. AtPRMT10 was overexpressed in Escherichia coli BL21-
CondonPlus (DE3) RIPL (Stratagene) and purified as described previously with some 
modifications (41). The cells were grown at 37 oC to an OD600 of 0.6 in Luria-Bertani media 
containing 50 μg/mL chloramphenicol and 50 μg/mL ampicilin. Protein expression was 
induced by the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final 
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concentration of 0.1 mM and the culture was grown for another 16 h at 18 oC. The harvested 
cells were resuspended in buffer A (50 mM Na phosphate pH 7.4, 500 mM NaCl and 20 mM 
imidazole) supplemented with 0.5 mM EDTA, 0.1% Triton X-100, 1 mM 
phenylmethylsulphonyl fluoride (PMSF), one tablet of a protease inhibitor cocktail (Roche), 
and 1 mg/mL lysozyme. After 45 min of incubation on ice, the resuspended cells were 
sonicated on ice for 3 min and the lysate was centrifuged at 50,000 × g for 60 min at 4 oC.  
The supernatant was passed through a 0.2 μm filter (Millipore) and then loaded onto a 5 mL 
high performance HisTrapTM column (GE Life Sciences), equilibrated with buffer A. The 
column was washed with 100 mL buffer A to remove nonspecifically bound proteins; the 
bound protein was then eluted with buffer B (50 mM Na phosphate pH 7.4, 50 mM NaCl and 
250 mM imidazole). The elutent was loaded onto a HiPrepTM 26/10 desalting column (GE 
Healthcare Life Sciences) equilibrated with buffer C (20 mM Tris-HCl pH 8.0 and 150 mM 
NaCl), and the protein-containing fractions were collected. To remove the His-MBP tag, TEV 
protease was added into the pooled protein fractions at a ratio of 1:100 (w/w) TEV to TraI.  
After 12 hr of incubation at 4 oC, the mixture was reloaded onto the 5 mL high performance 
HisTrapTM column (GE Life Sciences), equilibrated with buffer A. The flow-through fractions 
were collected and concentrated in a Centricon YM10 (Amicon) concentrator. Concentrated 
protein was loaded on a HiLoadTM 16/60 Superdex 200 column (GE, Life Sciences) 
equilibrated with sizing buffer (20 mM Tris-HCl pH 7.5, 250 mM NaCl, 5% Glycerol). 
AtPRMT10 containing fractions were concentrated, flash frozen in liquid nitrogen and stored 
at -80 oC.  Purified protein was >95% pure by SDS-PAGE.   
Crystallization, data collection, structure determination, and refinement 
Diffraction-quality crystals of AtPRMT10 (residues 11-383)-SAH complex were 
obtained by the hanging-drop vapour-diffusion method at 22 oC, with the mother liquid 
solution containing 0.1 M Tris-HCl pH 7.6, 2.3 M Na2HPO4 and 0.1 M arginine. Crystals grew 
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to the size of 250 × 200 × 50 μm in approximately 10 days. Since flash-frozen crystals 
diffracted poorly and could not be used for structural determination, diffraction data were 
collected from warm-mounted crystals to 2.6 Å resolution using a Rigaku X-ray generator 
MicroMax-007HF. Data from four different crystals were reduced and merged using the 
program HKL2000 (42) (Table 2.1). Data quality was examined using the program PHENIX 
(30). The structure was determined in space group P21 by molecular replacement using the 
program PHENIX (30). The crystal structure of rat PRMT3 (PDB entry, 1F3L), processed 
using the program chainsaw of the CCP4 package (43), was used as the template for 
molecular replacement. Due to the salient difference between AtPRMT10 and PRMT3 in the 
sequence of the dimerization arm, the dimerization arm of PRMT3 (residues 370-399) was 
not incorporated into the template. Since psudomerohedral twinning (approximately 50%) 
was detected with the crystals used for the structure determination, least square twin 
refinement was performed using the program PHENIX. The structural model was further 
built manually using the program Coot (44), and refined using the program PHENIX.  
Methyltransferase activity assay 
In vitro methyltransferase assays were performed as described previously (29). In 
brief, the reaction mixture contained 20 mM Tris-HCl pH 8.0, 4 mM EDTA, 1 mM DTT, 0.5 
mM PMSF, 4 μM S-[Methyl-3H]-Adenosyl-L-methionine (Perkin Elmer [NET155]) and 
indicated concentrations of AtPRMT10 and protein substrates. The reaction mixtures were 
separated on a 15% SDS-PAGE and stained with commassie blue. The gel was then 
treated with Amplifier (GE Healthcare Life Sciences), dried and exposed to Kodak Biomax 
MS film at -80 oC.   
Dynamic light scattering (DLS)  
The hydrodynamic radii of various AtPRMT10 constructs were measured by a 
DynoPro DLS system (Wyatt Technology Corporation). All samples and buffers (20 mM Tris-
66 
 
HCl pH 7.5, 100 mM NaCl, 0.5 mM EDTA) were filtered through 0.2 μM filters (Millipore) or 
centrifuged at 17,000 × g at 4 oC for 30 min before measurement. Three replicates were 
performed for each sample. The hydrodynamic radii and molecular weights of AtPRMT10 
samples were estimated using the assumption of globular protein shape.  
Molecular dynamics (MD) simulations  
MD simulations of AtPRMT10 were performed using the AMBER 2003 force field 
(45) as described previously (35). All production runs were generated using the PMEMD 
module of Amber 9.0 (46) with a 2 fs time step. The topology and parameter files were 
created using the LEaP program within AMBER (46). To maintain charge neutrality, the 
protein molecule was surrounded by a truncated octahedron of water and sodium ions in the 
simulation system. Electrostatic interactions were calculated using the particle-mesh Ewald 
algorithm (47) with a cutoff of 10 Å applied to Lennard-Jones interactions. Energy 
minimization was conducted using the SANDER package within AMBER (46). Equilibration 
consisted of 20 ps of constant volume conditions with heating from 100 to 300 K and 
subsequent 100 ps of constant temperature conditions.  
Simulation results were analyzed by the PTRAJ package in AMBER (46). The pair-
wise correlation coefficient, Cij, was calculated between the α-carbons of two residues as 
described by Sharma et al. (48). When the two residues i and j move in a correlated fashion 
(the angle between the motion of i and j is less than 90 º), 0<Cij≤1; when they move in an 
anti-correlated way (the angle between the motion of i and j is more than 90 º but less than 
180 º), -1≤Cij<0; finally, when they move in a non-correlated manner (randomly), Cij=0. The 
more positive the value of Cij is, the smaller the angle between the motion of the two 
residues is. Single-linkage clustering analysis was performed to identify groups of residues 
that move in a correlated or anti-correlated fashion, as described by Leese et al. (49). 
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2.6 FIGURE LEGENDS 
 
Figure 2.1 Crystal structure of AtPRMT10. (a) Domain architecture of AtPRMT10 from 
Arabidopsis thaliana. The SAM binding domain (residues 31-174) is shown in red, the β-
barrel domain (residues 175-186, 237-383) in blue, and the arm domain (or dimerization 
domain, residues 187-236) in yellow. (b) The crystal structure of the AtPRMT10-SAH 
complex with key secondary structure elements labeled (helices are labeled X through I and 
β-strands are numbered 1 through 15). The bound SAH is shown as sticks and spheres. 
The structure is colored as in Figures 2.1A-B. The first and last residues of AtPRMT10 are 
indicated. (c) Two views of the superimposition of AtPRMT10 (residues 31-383, magenta) 
with rat PRMT1 (residues 41-353, cyan, PDB entry 1ORI). Key structural differences 
between AtPRMT10 and PRMT1 (located in the dimerization domain and two loops in the β-
barrel domain) are indicated by arrows. (d) A stereo-view representation of SAH binding. A 
2.6 Å resolution simulated annealing omit map of SAH contoured at 2.5σ (blue mesh) is 
shown. Hydrogen bonds are indicated by red dashed lines. 
 
Figure 2.2 Structure-based sequence alignment of AtPRMT10, rat PRMT1 (PDB: 1ORI), 
rat PRMT3 (PDB: 1F3L), yeast RMT1 (1G6Q) and mouse CARM1 (PDB: 3B3F). 
Secondary-structure elements are shown across the top of the aligned sequences. Residue 
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numbers are provided on the right. Invariant and similar residues are highlighted in black 
and gray, respectively. Protein domains are colored as in Figures 2.1A-B. The four PRMT 
signature motifs are labeled. Residues involved in SAM binding and dimerization are 
highlighted by red and black stars, respectively.  
 
Figure 2.3 Dimer formation of AtPRMT10. (a) The crystal structure of an AtPRMT10 
dimer. The structure is colored and labeled as in Figures 2.1A-B. The location of each dimer 
interface is highlighted by an arrow. The dimer is formed by the interaction between the 
dimerization arm of one monomer and the outer surface of the SAM binding domain of the 
other monomer. (b) A surface representation of two views of an AtPRMT10 dimer, with two 
monomers are colored in gray and pink, respectively. (c) An expanded stereo-view of the 
dimer interface. Two monomers are colored as in Figure 2.2B. Residues involved in dimer 
formation are shown as sticks and labeled. Hydrogen bonds are indicated by red dashed 
lines. 
 
Figure 2.4 Surface representation of various PRMT paralogs, including rat PRMT1 
(PDB: 1ORI) (a), rat PRMT3 (PDB: 1F3L) (b), mouse CARM1 (PDB: 3B3F) (c) and 
AtPRMT10 (d). For consistency, the sequences N-terminal to helix X (including helix X) are 
deleted from the structure.  The dimensions of the central cavities are indicated.  
 
Figure 2.5 Methyltransferase activities of different AtPRMT10 constructs in vitro. (a) 
Indicated AtPRMT10 proteins (5 μg) were used for in vitro methylation activity assay. The 
reaction mixture was separated on a 15% SDS-PAGE and the autoradiograph of the gel is 
recorded. The experiments were performed in triplicate and a typical result is shown here. 
(b) Quantification of the results from Figure 2.5A. The relative activities presented here were 
calculated by considering the activity of wild-type AtPRMT10 over H2A as one. The activities 
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of AtPRMT10 mutants over H2A are significantly higher than that of wild-type enzyme (n=3; 
error bars represent SEM; Student t test *p < 0.03, **p < 0.002). (c) Methyltransferase 
activities of different AtPRMT10 constructs on H4, GST-H4 and H4N1-20.      
 
Figure 2.6 Surface electrostatic potential of AtPRMT10. Acidic surfaces are represented 
in red; basic surfaces in blue and neutral surfaces in gray. Acidic surface residues are 
labeled and colored based on their conservation among five PRMT paralogs as indicted by 
the sequence alignment in Figure 2.2 (black, conservation≥80%; green, 
40%<conservation<80%; blue, 20%<conservation≤40%; unique for AtPRMT10, red). The 
location of putative substrate binding grooves, the active site, the dimer interface and helix 
αX are highlighted and labeled. The top left view has the same orientation as in Figure 2.1B.  
 
Figure 2.7 AtPRMT10 exhibits a uniquely accessible active site. (a) Superimposition of 
AtPRMT10 (magenta) with rat PRMT1 (cyan, PDB: 1ORI), rat PRMT3 (yellow, PDB: 1F3L) 
and mouse CARM1 (blue, PDB: 3B3F). The bottom monomers are used for the alignment. 
The left view rotates about 90o along the vertical axis with respect to the view shown in 
Figure 2.3A. The angles of the rotation of AtPRMT10 and CARM1 relative to PRMT3 are 
shown. For clarity, the bottom monomers are not shown in the middle panel. The left edges 
of four monomers are indicated by vertical dashed lines with corresponding colors. The 
distance of the leftward translation of AtPRMT10 and CARM1 relative to PRMT3 are shown. 
The right panel is a schematic representation of the middle panel, with PRMT monomers 
shown as rectangles. The superimposed bottom monomers are shown and colored in white. 
(b)-(e) Views of the dimeric AtPRMT10, rat PRMT1, rat PRMT3 and mouse CARM1. The 
top and bottom monomers are shown in surface and ribbon representation, respectively. 
The cofactor analog SAH is shown in surface representation. The accessibility angle for the 
active site of each PRMT is labeled.  
70 
 
Figure 2.8 Conservation of total energy during AtPRMT10 simulations. Total energy, an 
indicator of the overall simulation stability, remains relatively constants during the course of 
MD simulations of monomeric PRMT10 (a) and dimeric PRMT10 (b). The average of the 
total energy is shown in a blue lines (a) and a green line (b), respectively. The final 10 ns of 
each simulation, highlighted by red square, was used for analysis.  
 
Figure 2.9 Effects of dimerization on the motion of AtPRMT10. (a) Local fluctuation of 
residues in dimeric and monomeric AtPRMT10. Major differences between monomeric and 
dimeric AtPRMT10, including the two N-terminal helices αY-αZ and the dimerization arm 
(αE-αG), are highlighted by arrows and labeled. (b) The structure of a dimeric AtPRMT10. 
The two monomers are colored in blue and green respectively. The regions that displayed 
dramatically reduced local fluctuations in dimeric PMT10 are colored in light green in one 
monomer and in light blue in the other monomer. The putative substrate sites are 
represented in orange balls. Covariance analysis of dimeric AtPRMT10 (c) and monomeric 
AtPRMT10 (d). The values of residue-residue correlation coefficients range from blue 
(anticorrelated, -0.62) to red (correlated, +1.0), with non-correlated residue pairs colored in 
yellow. Schematic representations of the secondary structure corresponding to the residues 
on x-axis and y-axis are presented from left to right and bottom to top. (e), (f) Clustering of 
correlated residues in dimeric AtPRMT10 (e) and monomeric AtPRMT10 (f). Clusters with 
correlation coefficients higher than 0.7 are shown in different colors (other than gray) and all 
other regions are colored in gray. SAH is shown as sticks and spheres to highlight the 
location of the SAM binding pocket, although it is removed from the crystal structures before 
MD simulations. (g) An expanded stereo-view of the SAM binding domain of Figure 2.9E, 
with the secondary structures labeled. 
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2.7 SUPPLEMENTAL FIGURE LEGENDS 
 
Supplemental Figure 2.1 Sequence alignment of AtPRMT10 orthologs in various 
plants. The aligned sequences include AtPRMT10 from A. thaliana (GeneBank accession 
number NP562720), G. max (ACU22946), V. vinifera (XP002285026), P. trichocarpa 
(XP002332378), Z. mays (NP001170456), S. bicolor (XP002436453) and O. sativa 
(EAY99613). The alignment was conducted using Clustal W, and then manually adjusted. 
The secondary-structure elements and residue numbering of AtPRMT10 are shown across 
the top of the sequences, colored and labeled as shown in Figure 2.1b. Residues involved in 
SAH binding and dimer formation are highlighted by red and black stars, respectively. Four 
PRMT signature motifs are labeled.   
 
Supplemental Figure 2.2 Conserved residues between AtPRMT10 and its paralogs, 
including rat PRMT1, rat PRMT3, yeast RMT1 and mouse CARM1, were mapped onto 
the structure of AtPRMT10. All three views are shown in surface representation where 
magenta represents residues with 100% conservation and orange denotes residues with 
high similarity. The top left view has the same orientation as shown in Figure 2.1b. The 
location of dimer interface and active sites are labeled.   
 
Supplemental Figure 2.3 Effects of dimerization on the motion of rat PRMT3. (a) Local 
fluctuation (as determined by B factors) of residues in dimeric and monomeric PRMT3 (PDB: 
1F3L). Major differences between monomeric and dimeric PRMT3, including the two N-
terminal helices αX-αY-αZ and the arm (αE-αF-αG) are highlighted by arrows and labeled. 
Schematic representations of the secondary structure corresponding to the residues on x-
axis are presented from left to right and bottom to top. Covariance analysis of dimeric 
PRMT3 (b) and monomeric PRMT3 (c). The values of residue-residue correlation 
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coefficients range from blue (anticorrelated, -0.62) to red (correlated, +1.00), with non-
correlated residue pairs colored in yellow. Schematic representations of the secondary 
structure corresponding to the residues on x-axis and y-axis are presented from left to right 
and bottom to top. 
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Resolution (Å) (highest shell) 33.0–2.61 (2.67–2.61)
Space group P21
Unit cell parameters
a, b, c (Å) 80.55,  86.69,  114.74
β (°) 89.97
Twinning fraction 0.5
Number of total reflections 48,404
Number of unique reflections 46,744
Rsyma (%) (highest shell) 12.0 (58.0)
Completeness (%) (highest shell) 96.6 (91.0)
Mean I/σ (highest shell) 13.0 (2.30)
Average redundancy 2.90 (2.60)
Rcrystb (%) (highest shell) 18.2 (35.0)
Rfreec (%) (highest shell) 22.4 (41.2)
RMSD
Bond lengths (Å) 0.007
Bond angles (°) 1.17
Dihedral angles (°) 16.2
Number of atoms per asymmetric unit
Protein 10,751
Ligand 104
Solvent 174
Rsym=∑|I−〈I〉|/∑I, where I is the observed intensity and 〈I〉 is the average 
intensity of multiple symmetry‐related observations of the reflection.
Table 2.1 Crystallographic data and refinement statistics
Rcryst=∑||Fobs|−|Fcalc||/∑|Fobs|, where Fobs and Fcalc are the observed and 
calculated structure factors, respectively.
Rfree=∑||Fobs|−|Fcalc||/∑|Fobs| for 5% of the data not used at any stage of 
refinement.
a
b
c
ND, not determined.
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Table 2.2 Oligomeric states of AtPRMT10 mutants
Monome
r size 
(kDa)
Gel‐
filtration 
size 
(− SAH) 
(kDa)
− SAH + SAH (1 mM)
Gel‐
filtration 
size/
monomer 
size
DLS 
Size
(kDa)
DLS size/
monomer 
size
DLS 
size 
(kDa)
DLS size/
monomer 
size
Wild 
type
43.1 80 1.8 93 2.2 92 2.1
ΔN10 42.1 ND ND 89 2.1 87 2.1
ΔN20 41.4 ND ND 83 2.0 83 2.0
ΔN30 40.4 68 1.7 74 1.8 80 2.0
Δ203
–225
40.8 34 0.9 66 1.6 61 1.5
Figure 2.1
75
Figure 2.2
76
Figure 2.3
77
Figure 2.4
78
Figure 2.5
79
Figure 2.6
80
Figure 2.7
81
Figure 2.8
82
(a)
(b)
Figure 2.9
83
84
Twin fraction
H test 0.449
Britton analysis 0.432
Maximum likelihood analysis 0.435
Results from the xtriage analysis in Phenix on the diffraction data used in this study.
Three related twin factions were determined.
Supplemental Table 2.1
Supplemental Figure 2.1
85
Supplemental Figure 2.2
86
Supplemental Figure 2.3
87
(a)
(b) (c)
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CHAPTER 3 
 
Crystal Structure of the HEAT Domain from the Pre-mRNA Processing Factor 
Symplekin  
 
 
 
3.1 INTRODUCTION 
 
Maturation of most eukaryotic pre-mRNAs requires cleavage and polyadenylation of 
the 3’-ends of primary transcripts. The 3’-end polyA tail ensures proper translation by 
delivering ribosomes to the mRNA(1); in amphibian oocytes, it was shown that translation 
was eliminated when the polyA tail addition was blocked by chemical modification(2). The 
polyA tail is also essential for protecting the message from exonucleases and for 
transporting the message from the nucleus to the cytoplasm(3).  The length of the polyA tail 
affects the stability of the message, and compromised stability has been shown to lead to 
inflammation, cancer, early developmental maladies and coronary ailments(4).  Thus, proper 
polyA tail addition to messenger RNA is required for proper cellular function.  
For polyadenylation to occur, the cleavage stimulation factor (CstF) and the cleavage 
and polyadenylation specificity factor (CPSF) must work in concert to recognize and orient 
the cleavage site for the addition of the poly (A) tail(5). The ~1,160 residue Symplekin  
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protein is proposed to be the scaffolding factor on which this large protein complex is 
assembled(3). Symplekin binds two members of the CstF macromolecular complex, CstF64 
and CstF77, in a mutually exclusive manner(6). Symplekin was identified as a stoichiometric 
component of the polyadenylation complex recently isolated from mammalian cells(7).   
Symplekin, CPSF73, and CPSF100 are part of a stable complex in D. melanogaster as 
shown via co-immunoprecipitation and co-depletion studies(8).   
Metazoan replication-dependent histone mRNAs are unique in that their 3’ ends are 
cleaved, but not polyadenylated. Interestingly, fractionation of HeLa cell nuclear extracts 
also identified Symplekin as a component of the histone pre-mRNA processing 
machinery(9). Additionally, an extensive RNA interference (RNAi) screen found Symplekin 
to be necessary for histone pre-mRNA processing in D. melanogaster; when Symplekin was 
RNAi-depleted, a histone pre-mRNA reporter(10) and endogenous histone mRNA(8) was 
misprocessed. These data lead to the hypothesis that Symplekin is essential for proper 3’-
end formation of canonical and histone mRNA by providing a scaffold on which protein-
protein interactions can occur (6, 9). 
Symplekin may also serve as bridging factor between the polyadenylation machinery 
and transcription regulators. Most recently, the N-terminal region of yeast Symplekin (Pta1) 
was found to interact with Ssu72, an RNA polymerase II C-terminal domain (CTD) serine 5-
phosphatase(11). The 124 N-terminal residues of mouse Symplekin interacts with heat 
shock factor 1 (HSF1). HSF1, Symplekin and other polyadenylation factors 
coimmunoprecipitate with HSF1 after heat shock, leading to the suggestion that HSF1 
stimulates both transcription and processing (12). Over expression of a non-DNA binding 
mutant HSF1 to interfere with the HSF1-Symplekin interaction decreased Hsp70 mRNA 
polyadenylation in stressed cells (12). Thus, the N-terminal region of Symplekin may be 
involved in protein-protein interactions that help couple transcription and processing.   
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Utilizing in silico methods (13-19), several potential HEAT repeats were identified in 
the N-terminus of D. melanogaster Symplekin. Protein domains formed by HEAT repeats 
are established protein-protein interaction scaffolds(20-27). HEAT repeats are composed of 
37-47 residues that fold into two anti-parallel helices connected by short (1-10 amino acids) 
linkers. Each set of helices can repeat 3 to 36 times, creating a HEAT domain(16). To 
characterize the N-terminal region of the Symplekins, the three-dimensional structure of D. 
melanogaster Symplekin residues 19-271 was determined using SAD phasing and refined 
to 2.4 Å resolution. Additionally, molecular dynamics simulations were employed to examine 
motion within this molecular scaffold. Taken together, these results provide the first detailed 
structural information on Symplekin, and indicate that the Symplekin HEAT domain may 
serve as a scaffold for protein-protein interactions essential to the mRNA maturation 
process. 
 
3.2 RESULTS 
 
3.2.1 Structure of the Symplekin HEAT Domain  
Examination of the 1,165 residue D. melanogaster Symplekin sequence using 
secondary structure prediction algorithms indicated that a series of HEAT repeats are 
present in the first 300 amino acids of the protein, and that this domain was expected to be 
conserved in symplekin orthologues(13-16, 19, 28). The predicted D. melanogaster 
Symplekin HEAT domain (residues 19-271) was cloned and expressed in E. coli, purified to 
homogeneity and crystallized using hanging-drop vapor diffusion. The structure of the 
selenomethionine-substituted Symplekin HEAT domain was determined using SAD phasing 
methods to 2.9 Å resolution, and the structure of the native Symplekin HEAT domain was 
then refined to 2.4 Å resolution (Table 3.1). Figure 3.1a illustrates a portion of the Symplekin 
HEAT domain final model in the original 2.9 Å resolution experimental density from SAD 
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phasing. Residues 19-271 of D. melanogaster Symplekin contain five HEAT repeats that 
fold into a single domain with a crescent shape (Figure 3.1b).  The ten HEAT helices 
(residues 22-256) are lettered conventionally for HEAT repeat domains (A for the convex 
and B for the concave surfaces).  Repeats 1-5 contain 37, 37, 47, 46, and 42 amino acids, 
respectively, values similar to those observed for established HEAT repeats(29). 
 An extended 31-residue loop (amino acids 187-217 and denoted loop 8) connects 
helices 4B and 5A in the Symplekin HEAT domain structure. Six polar interactions are 
formed between this loop and helices 4B and 5A, as well as two internal hydrogen bonds 
that occur between residues within the loop (Figure 3.1c). Specifically, within the loop, a 2.8 
Å hydrogen bond is formed between the backbone nitrogen of D192 and the side-chain 
oxygen of S195, and a 2.9 Å hydrogen bond is observed between the S203 backbone 
nitrogen and a D206 side-chain oxygen. Between the loop and the canonical HEAT domain 
scaffold, hydrogen bonds are observed between R258 of loop 10, M257 of α5B, K132 of 
α3B, and residues S195, G200, D201, and S203 of loop 8. Figure 3.2 illustrates the 
electrostatic potential of the concave surface of the molecule, indicating the presence of a 
positively charged patch as well as the predominantly negatively charged loop 8.  The 
average thermal displacement parameter (B-factor) for loop 8 is 69 Å2, while the overall 
average B-factor for the structure is 52 Å2.  One crystal contact involving loop 8 exists in the 
refined crystal structure, between D209 in loop 8 and E69 of α2A in a symmetry-related 
monomer.   
 
3.2.2 Conservation in Symplekin Orthologues  
In addition to the reported similarity between amino acids 300-800 of human and 
yeast Symplekin(6), the HEAT repeats within the N-terminal regions of Symplekin 
orthologues, including the residues on the concave surface and loop 8, are reasonably well 
conserved. Figure 3.3 presents a sequence alignment of the N-terminal ~300 residues of 
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Symplekins from eight representative species: Drosophila melanogaster, Homo sapiens, 
Xenopus laevis, Strongylocentrotus purpuratus, Caenorhabditis elegans, Arabidopsis 
thaliana, Schizosaccharomyces pombe, and Saccharomyces cerevisiae.(30). While only six 
amino acid positions (99, 152, 179, 180, 251 and 258) are 100% identical within the domain, 
38% are highly similar (defined as 6 or more species containing a similar amino acid type).  
Of these similar residues, 75% are nonpolar and map to positions in the hydrophobic core of 
the D. melanogaster HEAT domain structure.   
When comparing only the three sequences most closely related to D. melanogaster 
(H. sapiens, X. laevis and S. purpuratus), it was found that the hydrophobic core of 
Symplekin contains 28 residues that are completely conserved (Figure 3.4a; see also Figure 
3.3). In addition, in considering the concave, convex and loop regions of Symplekin, it is 
evident that the majority of identical residues fall on the concave surface and within the 
loops (Figures 3.4b, 3.4c). The sixteen conserved residues found on the concave surface 
account for >20% of the total conserved residues in this HEAT domain (Figure 3.4b, yellow).  
Loop regions projecting from the concave surface account for ten conserved residues, five 
of which are in loop 8 (Figure 3.4b, cyan). In contrast to the concave side, the convex 
surface contains only 4 conserved residues (Figure 3.4c, green). These data indicate that 
the HEAT domain is likely conserved in the N-terminal regions of the Symplekins of known 
sequence, and that the hydrophobic core, concave surface and loop 8 are the regions most 
highly conserved.  
Although sequence variation exists at many positions in the more distant species 
(sequences in grey, Figure 3.3), examination of secondary structure predictions indicates 
that the helical HEAT-like fold is preserved in each putative Symplekin orthologue(31). All 
seven sequences have unstructured regions aligning with D. melanogaster loops, including 
the extended loop 8 (underlined in Figure 3.3). While S. cerevisiae secondary structure 
predictions in the regions of α2B and α4A include sequence inserts, homology modeling 
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supports the conclusion that this protein adopts a HEAT-like repeat structure. Taken 
together, these data indicate that the orthologue sequences shown in Figure 3.3 are likely to 
resemble the α-helical D. melanogaster Symplekin HEAT domain structure. 
 
3.2.3 Symplekin HEAT Repeats are Classified with Scaffolding Proteins 
The closely related HEAT and armadillo structural domains have been sub-classified 
based on specific amino acid sequences that coincide with functional categorization(20).  To 
further characterize the Symplekin’s N-terminal domain, each of the repeats were 
structurally aligned and the sequences were compared to the sequence classifications for 
three types of HEAT sequences (ADB, AAA and IMB), as developed by Andrade et al.(20).  
The AAA, ADB, and IMB HEAT classes all exhibit a similar pattern of hydrophobic residues 
and contain conserved residues D19 and R/K 25 near the intrahelical loop, while the 
sequence logo of the ADB class also contains D/N21 and V/I24(20).  Symplekin contains the 
ADB pattern: HEAT repeat 2 contains D77, N79, V92, and K83, HEAT repeat 3 includes 
D114, N115, I120, and K121, while HEAT repeat 4 contains 167D, 170N, 173I and R174. 
Terminal HEAT repeats are more difficult to classify because they have a different set of 
packing constraints(20).  The highly conserved P11 of the AAA and IMB classes is lacking in 
the ADB class, and is also lacking in the HEAT repeats 2, 3 and 4 of Symplekin. Taken 
together, the residues in the three central Symplekin HEAT repeats indicate that Symplekin 
may belong to a small ADB subclass of HEAT repeats, a family containing mainly α, β-
adaptin and β-coat proteins that function as scaffolds for protein binding and transport.  This 
sub-classification supports the hypothesis that the Symplekin HEAT domain has a structure 
appropriate for protein-protein interactions.   
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3.2.4 Symplekin HEAT Structurally Aligns with Protein-Binding Scaffolds  
The structure of the D. melanogaster Symplekin HEAT Domain was examined using 
Dali to identify proteins of similar structure(32).  While nearly 200 protein structures exhibited 
homology with the Symplekin HEAT Domain, the closest structural neighbors were 
serine/threonine-protein phosphatase 2A PR65/A subunit (PDB 1b3u), Cullin-associated 
protein Cand1 (PDB 1u6gc), and karyopherin-α (PDB 1ee4), all of which have HEAT or 
armadillo (ARM) repeats.  Experimental evidence indicates that their HEAT/ARM repeats 
are involved in protein-protein interactions and the majority of these domains utilize their 
concave face as a protein binding or scaffolding surface(22, 24, 27, 33-36).  Recall that 
amino acid conservation supported the functional importance of the concave surface and 
loop 8 of the Symplekin HEAT domain (see above).  Symplekin superimposes on the 
structure of Cand1 (TIP120) of the Cand1-Cul1 complex with only 10% sequence identity 
but with 3.8 Å RMSD over 203 aligned residues, and a Z-score of 14.7 (Figure 3.5a).  The 
concave surface of Cand1 is employed in binding Cul1 to inhibit Cul1 from forming the E3 
ubiquitin ligase complex(22).  Symplekin structurally superimposes on yeast karyopherin-α 
with 11% identity over 196 Cα positions, a 5.0 Å RMSD, and a Z-score of 14.2 (Figure 
3.5b)(32). The concave surface angles of each protein were calculated by measuring the 
angle between three concave surface Cα residues on helices 1B, 3B and 5B at three 
positions on these helices: near the N-terminus, the center, and near the C-terminus.  The 
concave surface angle for the helical N-termini of Symplekin, Cand1 and karyopherin-α are 
144°, 100°, and 153°, respectively; for the helical centers are 141°, 124°, and 157°, 
respectively; and for the helical C-termini are 107°, 137°, and 150°, respectively.  The twist 
of each HEAT domain was determined by comparing the angle between the helical axes of 
helices 1B and 5B, and found to be 5°, 10°, and 77° for Symplekin, Cand1 and karyopherin-
α, respectively.  Thus, while the overall concave surface angles of each HEAT domain are 
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similar, Symplekin and Cand1 exhibit significantly less domain twist than does karyopherin-
α.  
The core of yeast karyopherin-α is a canonical ARM repeat with acidic concave 
surface regions equipped to bind basic nuclear localization signals (NLS)(36). It has been 
reported that D. melanogaster karyopherin-α3 binds to the positively charged NLS of HSF1, 
and residues 1-124 of Symplekin interact with HSF1(12, 37).  Fly and yeast karyopherin-α 
sequences share 50% identity and maintain a similar electrostatic surface.  There are no 
extended loops in either karyopherin-α sequence.  However, with respect to loop 8, it is 
clear from the structural superposition of karyopherin-α and the Symplekin HEAT domain 
that the position of loop 8 clashes with the NLS sequence bound to the surface of 
karyopherin-α (Figure 3.5b).  Loop 8 of Symplekin is negatively charged and could provide 
an alternative binding region for the positively charged NLS (Figures 3.2, 3.5b).  Taken 
together, the observations that karyopherin-α3 and Symplekin contain similar structural 
motifs, have similar electrostatic surfaces, and both bind to HSF1 support the conclusion 
that Symplekin has characteristics of a protein-binding scaffold. 
 
 3.2.5 Loop 8 Impacts Symplekin HEAT Domain Motion 
Molecular dynamics (MD) simulations have been used to investigate the manner in 
which HEAT and ARM domains change conformational states upon ligand binding, and to 
design ideal ARM domains for general peptide binding(38-40). Our attempts at 
biochemically characterizing the interactions between the Symplekin HEAT domain with D. 
melanogaster CstF64 and Ssu72 through amylose-affinity pull down assays were 
unsuccessful due to non-specific interaction with the MBP tag. However, these interactions 
have been shown indirectly in Symplekin orthologues. Instead, we employed MD to examine 
how loop 8 impacts the overall and correlated motions within the Symplekin HEAT domain 
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structure. Three models of the Symplekin HEAT domain were subjected to 10 ns MD 
simulations: Wild-Type containing a complete loop 8, a model in which the ten polar 
residues in loop 8 were all replaced with serine (Poly-Ser Loop 8; serine was chosen to 
place small polar side chains in this surface-exposed loop), and a model in which loop 8 is 
replaced with a short turn (Short Loop 8) (Figure 3.6). The Short Loop 8 mutant was 
designed with the intention to mimic the minimal loops commonly seen between HEAT 
repeats.  Comparing the Short Loop 8 with Wild-Type Symplekin was expected to show the 
role loop 8 plays in the motion of the Symplekin HEAT domain. The Poly-Ser Loop 8 model 
was expected to show whether specific residues on the loop were important for Symplekin 
HEAT domain motion.  
Simulations of each Symplekin model were performed in triplicate using different 
random number generator seeds. Data used for analysis of each individual simulation was 
collected from 10 consecutive nanoseconds of the same conformational ensemble 
(designated by a consistent root mean square deviation from the starting crystal structure) 
(Figure 3.7a).  The models were analyzed with respect to both the overall degree of motion 
seen in Cα atoms (observed as the atomic position fluctuations (APF) of each Cα) as well as 
the behavior of each Cα with respect to all other Cα atoms.  Wild-Type loop 8 and Poly-Ser 
loop 8 simulations exhibit nearly identical overall motion in loop 8 Cα atoms as well as 
throughout the entire protein (Table 3.2). The similarity of the mean APFs between the Wild-
Type loop 8 and the Poly-Ser loop 8 indicates that the specific amino acids in loop 8 do not 
control the overall motion in either loop 8 or the entire HEAT domain.  The Short Loop 8 
simulation’s overall degree of motion was also found to be similar to both the Wild-Type loop 
8 and Poly-Ser loop 8 simulations, indicating that the presence of the extended loop 8 does 
not significantly influence the overall motion of the HEAT domain.   
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Correlation-anticorrelation plots, which provide information on the relative motion of 
each residue pair during an MD trajectory, were then generated for these HEAT domain 
simulations.  In Figures 3.7b-d, red indicates correlated motion between two Cα positions 
(e.g., motion in the same direction), blue indicates anti-correlated motion (e.g., in the 
opposite direction), and yellow indicates no correlation in motion (two residues that move 
randomly with respect to one another). Both the Wild-Type and Poly-Ser Symplekin HEAT 
domain simulations exhibit similar patterns and levels of correlated and anticorrelated 
motion (Figures 3.7b, 3.7d), indicating that the dynamics of the HEAT domain is maintained 
regardless of the specific residues present in loop 8.  In contrast, however, the Short loop 8 
simulation exhibits noticeably higher levels of correlated and, particularly, anticorrelated 
motions (Figure 3.7c), indicating that removal of the loop increases the degree of specific 
residue-to-residue motions within the HEAT domain. Taken together, these results indicate 
that the presence of loop 8, but not specific polar residues on the loop, reduces specific 
pairwise motions in the Symplekin HEAT domain. Thus, maintaining an extended loop in this 
location in Symplekin (e.g., see Figure 3.3) may disrupt specific domain movements to 
provide the neutral scaffold for protein-protein interactions. 
 
3.3 DISCUSSION 
The 1165-residue Symplekin protein is a component of the 3’-end processing 
machinery critical to both canonical and histone messenger RNA(3, 6, 9).  While structural 
information is available for many of the other 3’-end processing factors(41-49), no structures 
have been reported for any region of Symplekin to date.  Here, we show that residues 19-
271 of D. melanogaster Symplekin fold into a HEAT repeat structure with an extended loop 
8 that is conserved in the Symplekins of known sequence. Examination of the electrostatic 
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potential of the Symplekin HEAT domain reveals that the concave surface is positively 
charged, while the ridge formed by the even-numbered loops exhibits a slight overall 
negative charge (Figure 3.2). Sub-classification of Symplekin’s HEAT repeats and structural 
alignments indicate that these regions of Symplekin may act as a scaffold for protein-protein 
interactions.  Indeed, HEAT domains are well established platforms for macromolecular 
complex formation (e.g., Figure 3.5). For example, crystal structures and molecular 
dynamics studies of importin-β reveal four regions for peptide binding within 5 HEAT 
repeats(50).  
Takagaki et al. has reported that the central region (residues 300-740) of human 
Symplekin is 31% similar to S. cerevisiae Symplekin orthologue, Pta1(6).  Using the crystal 
structure reported here as a guide, we further examined Symplekin orthologue sequences 
and have found that the N-terminal region of Pta1 exhibits some homology to the equivalent 
region of D. melanogaster Symplekin.  All of the orthologues contain similar 
hydrophobic/hydrophilic residue distributions and have greater than 60% α-helical content in 
their N-terminal regions (Figure 3.3).  Specifically, Pta1 maintains hydrophobic residues in 
79 out of the 125 hydrophobic positions present in the D. melanogaster N-terminal HEAT 
domain and 33 residues are identical between these two species.  Loop 8 lacks secondary 
structure in all species investigated, and three residues are identical and nine residues are 
similar between Pta1 and D. melanogaster Symplekin within this 31-residue region. These 
data support the conclusion that the N-terminus of S. cerevisiae Pta1 likely encodes α-
helical HEAT-like domain similar to the D. melanogaster HEAT domain structure reported 
here.   
Several published reports map specific protein docking sites within the Symplekin 
HEAT region.  The HEAT domain of the yeast Symplekin homologue Pta1 has been shown 
to bind to both Ssu72 and Glc7(11, 51) and a portion of the mouse Symplekin HEAT domain 
interacts with HSF1(12).  Ssu72 and Glc7 have been implicated in the regulation of 3’-end 
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processing.  Depletion of the Glc7 phosphatase causes an accumulation of phosphorylated 
Pta1 and a subsequent reduction in 3’-end polyadenylation; this effect can be rescued by 
the addition of either Glc7 or unphosphorylated Pta1 back into the processing reaction(51).  
The binding of yeast Symplekin homologue Pta1 to Ssu72, an RNA polymerase II C-
terminal domain phosphatase, may position the 3’-end processing machinery in proximity to 
primary transcripts to promote facile processing(11). Similarly, Symplekin may link 3’-end 
processing to transcriptional control via contacts with transcription factors like HSF1.  The 
binding of the HEAT domain of mouse symplekin to HSF1 promotes polyadenylation of 
Hsp70 mRNA in heat stressed cells(11, 12).  Taken together, these data indicate that the 
Symplekin HEAT region provides a platform for enzymes and other proteins critical to 
modulating 3’-end processing.  
GST pull down studies and yeast two-hybrid assays provide information on the 
specific Symplekin regions involved in these protein-protein interactions (Figure 3.8).  
Binding to Glc7 was maintained using Pta1 ∆1-100, while removal of Symplekin residues 1-
200 abolished Glc7 binding(51).  Indirectly, this indicates Symplekin HEAT repeats 3, 4 and 
loop 8 (Pta1 residues 100-200) are used in binding to Glc7(51).  Ssu72 requires Symplekin 
HEAT repeat 2 for optimal binding (Pta1 residues 51-76)(11), and HSF1 binds to residues 
HEAT repeats 1-3 (mouse Symplekin 1-124)(11, 12, 51).  The exact regions of Symplekin 
required for interacting with the core 3’-end processing machinery, CstF and CPSF, have 
not been determined; however, it has been shown that some processing in yeast can occur 
with a ∆1-300 Pta1 construct(11).  Therefore, we propose a model where several regulatory 
proteins bind in a mutually exclusive manner to distinct sites on the Symplekin HEAT 
domain, whereas the C-terminal region of the protein associates with central members of the 
3’-end processing machinery (Figure 3.8).    
Molecular dynamics simulations conducted on the Drosophila Symplekin domain 
structure provides preliminary insight into the motions in this region of the protein.  Although 
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the timescale on the trajectories were only 10 nsec and the domain was examined in 
isolation, it was clear that the loop 8 is involved in disrupting the dynamic relationship 
between the residues across the entire HEAT domain (Figure 3.7).  These observations 
suggest that the wild-type Symplekin HEAT domain may be tuned to adopt a more neutral 
range of motions to prepare it for binding to different protein partners.  Changes in flexibility 
of wild-type proteins relative to specific mutants have been reported in previous molecular 
dynamics studies(52).  Additionally, our characterization of the Symplekin HEAT domain 
agrees well with published MD studies of Armadillo and HEAT domain proteins.  
Examination of Cse1p by MD indicates that a particularly negatively charged loop (insert 19) 
helps to poise the structure in an open conformation to facilitate binding to RanGTP and 
Kap60p(39).  Loop 8 in D. melanogaster Symplekin also exhibits a slight overall negative 
charge and may play a similar role in preparing the domain to bind to protein partners Glc7, 
Ssu72 or HSF1.  In simulations of importin-β, the ligand bound states are curved in shape, 
but upon ligand release the domain opens to produce more elongated states(39, 40).  The 
Symplekin HEAT domain may also employ such “tertiary disorder”(40) in conforming to 
different protein-binding partners.  It is likely that there may be additional partners that 
interact with the HEAT domain that may be involved in regulating histone pre-mRNA 
processing.   
Combining our structural and molecular dynamics results with biochemical studies, 
we have classified the Symplekin HEAT domain as a scaffold for the binding of proteins 
critical to modulating 3’-end mRNA processing. Utilizing sequence conservation data 
(Figures 3.3, 3.4), future biochemical and mutagenesis studies will be conducted with this 
HEAT domain to identify specific residues vital for binding to Glc7, Ssu72 and HSF1.  A 
preliminary cryo-EM image of the purified 3’-end processing complex including Symplekin, 
CPSF, CstF and CFI has recently been determined at low resolution(7) and crystal 
structures exist for several components of the eukaryotic 3’-end processing machinery, 
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including CPSFs 30, 73, 100, CstF64 and 77 and CFIm-25(41, 42, 46, 47).  Thus, a range of 
efforts are underway to understand the intricate macromolecular relationships required for 
the catalytic and regulatory aspects of 3’-end processing machinery.  The structure of the 
Symplekin HEAT domain presented here provides an additional piece of this complex 
structural puzzle. 
 
3.4 METHODS 
Expression and Purification of Symplekin HEAT Domain 
The following software programs were utilized to predict the structural elements 
within Symplekin: BLAST, Jpred(15), PHYRE(17), pFam(16), InterProScan(19), 
ScanSite(53), PredictProtein(18), RONN(54) and COILS(55). The disordered regions 
include 1-18, 452-544, and 1116-1165. A HEAT-like domain was predicted between 
residues 19-271. Based on these analyses, residues 19-271 of D. melanogaster Symplekin 
were cloned into the expression vector pMCGS9, which provided N-terminal 6-histidine and 
maltose-binding protein (MBP) tags followed by a Tobacco Etch Virus (TEV) protease 
site(56).  Escherichia coli BL21 (DE3) gold cells (Stratagene) were transformed with this 
constructed plasmid and cells were grown at 37 °C in 1.5 L of terrific broth supplemented 
with 50 mg/L ampicillin until an A600=1.0-1.2. The temperature was dropped to 18 °C and 0.1 
mM of IPTG was added to induce protein expression until a final OD A600=4.5. The cells 
were harvested by centrifugation and resuspended in nickel buffer A (5 mM imidazole, 50 
mM potassium phosphate, pH 7.4, 150 mM NaCl, 1 mM DTT, 0.01% sodium azide) and 
stored at -80°C.   Thawed cells were lysed by sonication in the presence of DNase and 
protease inhibitors, and centrifuged at high speed for 60 minutes to produce a cleared 
lysate. The histidine-tagged protein was purified from the lysate by nickel affinity 
chromatography.  Nickel buffer B (500 mM imidazole, 50 mM potassium phosphate, pH 7.4, 
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150 mM NaCl, 1 mM DTT, 0.01% sodium azide) was used to elute the protein from the 
column with a gradient of 5-100% B. To cleave the 6xHis-MBP fusion protein from the 
Symplekin 19-271 polypeptide, 2% TEV protease by mass TEV/mass Symplekin was 
added. Protein was dialyzed into nickel buffer A during TEV cleavage. A second nickel 
column purified the now un-tagged Symplekin from the 6His-MBP tag. A polishing step of 
size exclusion chromatography (Column: Superdex 75, GE Healthcare; sizing buffer: 10 mM 
HEPES, pH 8.0, 50 mM NaCl, 1 mM DTT and 0.01% sodium azide) produced >95% purity 
by SDS PAGE. A selenomethionine-substituted form of D. melanogaster Symplekin residues 
19-271 was produced using B834 cells, a methionine auxotroph cell line. Cells were grown 
in selenomethionine specific media (Athena) supplemented with 50 mg/L selenomethionine. 
Expression and purification procedures were identical to those listed above for the native 
protein. 
Crystallization and X-ray Data Collection 
Native and selenomethionine-substituted Symplekin proteins were concentrated to 3-
6 mg/mL in sizing buffer. Crystallization was performed by hanging drop diffusion at 22 °C 
with mother liquor consisting of 0.4-0.5 M sodium citrate, 25-28% PEG 3350, 10 mM 
HEPES, pH 8.0, 0.01% N3Na and 1 mM DTT. Each crystallization drop contained 1 μL of 
protein and 1 μL of well solution. Diamond shaped crystals grew within one week, with 
maximal dimensions of 300 μm x 60 μm x 60 μm. Crystals were cryoprotected in mother 
liquor plus 35% PEG 3350 and flash-cooled in liquid nitrogen. Diffraction data were collected 
at 100K using Sector 22-BM (SER-CAT) of the Advanced Photon Source at Argonne 
National Laboratories. A SAD data set was collected on crystals containing 
selenomethionine-substituted protein at 0.97190 Å; a native data set was collected using 
crystals containing wild-type protein at 0.97958 Å. DENZO and SCALEPACK in HKL-2000 
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were employed for data indexing and scaling(57). The crystals were of the space group 
P41212 with unit cell dimensions of a, b = 68.7 Å, c = 138.5 Å and α, β, γ = 90° (Table 3.1). 
Phasing, Model Building and Refinement 
The SGXPRO software package, an interface for programs including SHELXD and 
SOLVE/RESOLVE, was employed to identify heavy atom sites and provide initial 
phases(58).  A Matthews’s coefficient value of 2.9 indicated that 1 molecule was expected in 
the asymmetric unit with 57.6% solvent.  Six methionine residues were present in Symplekin 
19-271, thus six Se sites were expected.  SHELXD and SOLVE identified all six Se atom 
positions, and initial phases were calculated to 2.9 Å.  RESOLVE was used for density 
modification and to provide an initial model. After these steps, the overall figure of merit was 
0.69.  
The model was built further by hand using COOT(59).  Initially, all helices were built 
with alanine residues.  Loops were added over several rounds of refinement to connect the 
helices.  Finally, side chains were placed in the model.  This 2.9 Å model from SAD was 
refined using REFMAC5 at this stage to R and Rfree values of 0.353 and 0.419, respectively.  
To phase the 2.4 Å native data set, the model refined using the SAD data was used in 
molecular replacement(60).  Further refinement was conducted by building and validating 
the model in COOT, and employing both CNS and REFMAC5 to produce R and Rfree values 
of 0.2068 and -0.2653, respectively (Table 3.1).  For both the original SAD data and the final 
native data, 5% of the data were set aside for the free-R and not used at any stage of 
refinement.  The final model, consisting of 248 residues (no density was present for residues 
19-21 and 271) and 142 water molecules, was validated with PROCHECK and 
Molprobity(61).  Figures 3.1, 3.2, 3.4, 3.5 and 3.6 were created using PyMOL(62). 
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Sequence and Structural Alignments 
 The amino acid sequence of D. melanogaster Symplekin was entered into NCBI 
BLAST to retrieve homologous protein sequences.  Sequences (with NCBI Accession 
numbers) from Drosophila melanogaster (NP_649580.1), Homo sapiens (NP_004810.2), 
Xenopus laevis (NP_001079691.1), Strongylocentrotus purpuratus (XP_783721.2), 
Caenorhabditis elegans (NP_505210.2), Arabidopsis thaliana (NP_195760.1), 
Schizosaccharomyces pombe (NP_594351.2) and Saccharomyces cerevisiae 
(AAA34919.1) were  selected to represent a broad spectrum of species containing 
Symplekin.  The sequence alignment, prepared using ClustalX and refined using several 
rounds of PSI-BLAST, was abbreviated to display only the portion of the sequences that 
align with the D. melanogaster HEAT domain structure (Figure 3.3).  The structural 
alignment shown in Figure 3.4 was prepared using Dali(32). To characterize the HEAT 
repeats, each Symplekin HEAT repeat was structurally aligned to HEAT repeat 2.  
Molecular Dynamics Simulations  
 COOT(59) was utilized to create the Symplekin modeled Short loop 8 and Poly-Ser 
loop 8.  For the Poly-Ser model, the residues changed to serine were D192, E193, D194, 
K197, R198, D199, D201, D209, H210, R215.  To design a short turn to replace loop 8 in 
the Short loop model, many other HEAT repeat proteins were examined to identify common 
linkers and it was determined that six residues are sufficient to bridge a 10.6 Å gap.  To 
keep this linker as authentic as possible, residues on each end of the loop were maintained 
and connected with a glycine, a residue common in loops of HEAT repeats.  Native residues 
190-214 were completely removed. Thus, the modeled Short loop 8 is 187-LQSGRR-216. 
Residues 187-216 were used to calculate the relative APF values for loop 8 in each 
simulation. 
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 Molecular dynamics simulations of the Symplekin HEAT domains were performed in 
triplicate using the AMBER 2003 force field with at 2 fs time step(63). LEaP was used to 
generate the topology and parameter files, SANDER performed the 5000 steps of energy 
minimization, which included constant volume followed by constant temperature 
equilibration, the PMEMD module was used for the production runs, and PTRAJ was utilized 
for analysis of the results(63). TIP3P water molecules were used to generate the solvated 
structure(64), and electrostatic  interactions were calculated using the particle-mesh Ewald 
algorithm with a cutoff of 10 Å applied to Lennard-Jones interactions(65). All molecular 
dynamics simulations were conducted and analyzed as described previously(66).  
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3.6 FIGURE LEGENDS 
 
Figure 3.1 Symplekin HEAT domain structure. (a) A wall-eyed stereo view representation 
of a portion of the final model in the original experimental electron density from SAD phasing 
contoured to 1σ.  (b) The overall structure of the HEAT domain within Symplekin.  Helices 
are lettered and numbered according to classical HEAT naming; the A helices create the 
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convex face, while the B helices create the concave face.  The rainbow denotes the N to C 
progression of residues 22-270.  The B helices are in light colors corresponding to their 
counterpart A helices. For example, 1A is red and 1B is pink.  The extended loop 8 is in 
cyan. (c) Polar contacts within the loop 8 region of Symplekin. Arginine 258 and aspartic 
acid 201 form a salt bridge that anchors loop 8 to helix 5B.  Lysine 132 forms a salt bridge 
with G200 to hold the loop in place with respect to helix 3B.  A variety of other polar contacts 
position the extended loop 8 at the ends of helices 3-5 including S195-D192, M257-S195, 
M257-R258, R258-S203, S203-D206. 
 
Figure 3.2 Electrostatic representation of the concave surface of Symplekin’s HEAT 
domain. Red denotes negatively charged surfaces, blue denotes positively charged 
surfaces.  The molecule is rotated 90° along the horizontal axis of Figure 3.1b, to orient the 
concave surface towards the reader.  The concave surface is mainly positively charged, 
while loop 8 is negatively charged. 
 
Figure 3.3 Sequence alignment of Symplekin orthologues in various species. The 
secondary structure elements and numbering across the top of the sequences correspond 
to the D. melanogaster structure in Figure 3.1c. Pink blocks denote the conserved D/E19 
and K/R25 required for HEAT repeats, and blue colored blocks represent the HEAT repeat 
hydrophobic signature. The more distantly related orthologue sequences are shown in grey.  
Sequences and alignment were made using PSI-Blast and ClustalX. Secondary structure 
prediction and models of each sequence were predicted using PHYRE. Black underline 
denotes regions of disorder predicted by PHYRE, non-underline sequences are all predicted 
to be α-helical. 
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Figure 3.4 Conserved residues among four closely related Symplekin orthologues (H. 
sapiens, X. laevis, D. melanogaster, S. purpuratus) mapped onto the HEAT domain 
structure. (a) View of the hydrophobic core where purple represents residues with 100% 
conservation.  (Molecule is rotated 180° on the vertical axis with respect to Figure 3.1b.)  (b) 
View of the concave surface colored as follows: yellow denotes 100% conserved residues 
that project out of the concave surface, cyan residues are conserved in loop regions, and 
gray residues are not 100% conserved. (Molecule is rotated 90° on the horizontal axis with 
respect to Figure 3.4a.)  (c) View of the convex surface colored as in A, except green 
denotes conserved residues that project from the convex surface.   
 
Figure 3.5 Symplekin structural alignment with two most closely related structures.  
(a) Symplekin superimposed with Cand1 of the Cand1-Cul1-Roc1 complex (PDB 1u6g).  
Cand1 structure is in grey, Cul1 in white, and Roc1 is removed for figure clarity.  Symplekin 
helices and surface have coloring from Figure 3.1b.  A closer look at aligned individual 
helices shows that α3B is extended in comparison to the aligned helix in Cand1.  Loop 8 is 
unique to Symplekin compared to Cand1.  (b) Symplekin superimposed with karyopherin-α 
(PDB 1ee4). Karyopherin-α is grey, the nuclear localization signal (NLS) peptide bound to 
karyopherin-α is magenta.  Symplekin maintains coloring from Figure 3.1b. Loop 8 docks 
into α-helices 3B, 4B and 5B, and lies in the same region that the NLS peptide occupies on 
karyopherin-α. 
 
Figure 3.6 Symplekin HEAT domain structures used for molecular dynamics 
simulations. The labeled residues in loop 8 are mutated to serine for the Poly-Ser Loop 8 
simulation. To prepare the short loop model, residues 191-214 were removed and wild-type 
residue 189 was connected to 215 by mutating F190G.  
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Figure 3.7 Truncation of loop 8 increases correlation/anticorrelation  within 
Symplekin’s HEAT domain. (a) All atom root mean squared deviation in position over the 
simulation time scale.  Boxed area between 5-15 ns represents section of time used in data 
analysis.  (b-d) Correlation/anticorrelation plots for Wild-Type (b), Short Loop 8 (c), and 
Poly-Ser Loop 8 (d) from molecular dynamics simulations.  Red represents correlated 
movement, blue represents anticorrelated movements and colors between represent less 
correlated movements according to the given color scale.  Each axis represents the Cα 
position for the given residue within the HEAT domain (going from N- to C- terminus from 
both left to right and from bottom to top).  The secondary structural elements are colored 
consistently with Figure 3.1b. 
 
Figure 3.8 Symplekin model for protein scaffolding.  A diagram illustrating Symplekin 
HEAT domain’s interaction with known binding partners. Secondary structural elements and 
residue numbers are labeled according to the structure. HSF1, Ssu72 and Glc7 bind to 
specific regions of the HEAT domain as described in the text. The C-terminal region of 
Symplekin has yet to be structurally characterized with respect to binding to the core 3’-end 
machinery.   
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Table 3.1
Data collection
X‐ray source APS SER‐CAT BM‐22
Space Group P41212
Unit cell a,b,c (Å); α, β, γ (°) 68.7, 68.7, 138.5; 90, 90, 90
Data set SeMet Native
Wavelength (Å) 0.97190 0.97958
Resolution (Å)    (highest shell) 50.0‐2.9     (3.0‐2.9)
50.0‐2.4         
(2.49‐2.40)
Rsym 9.4 (34.4) 8.0 (41.9)
I/σ 22.4 (1.0) 24.8 (1.9)
Completeness (%) 78.1 (6.7) 96.1 (79.6)
Redundancy 10.4 (1.6) 6.4 (2.8)
Phasing
Mean Figure of Merit
Centric 0.71
Acentric 0.68
All 0.69
Refinement
Resolution (Å) 50.0‐2.4
No. reflections 12465
Rwork 0.2068
Rfree 0.2653
Molecules per asymmetric unit (AU) 1
No. of amino acids per AU 248
No. of waters per AU 142
Average B‐factors 46.37
R.M.S. deviations
Bond lengths (Å) 0.0059
Bond angles (°) 1.20
Ramachandran (%)
Favored 96.76
Outliers 0.40
•Rsym=|I-Imean|/I where I is the observed intensity and Imean is the average intensity of 
several symmetry related observations.
•Rwork=|Fo-Fc|/Fo where Fo and Fc are the observed and calculated structure factors, 
respectively.
•Rfree=calculated as above for 5% of data not used in any step of refinement.
Data collection, phasing, and refinement statistics. 
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Table 3.2
Model Wild‐type loop 8 Poly‐Ser loop 8 Short loop 8
Residues All Loop 8 All Loop 8 All
Mean 1.0 ± 0.024 1.2 ± 0.035 1.1 ± 0.087 1.4 ± 0.32 1.2 ± 0.036
Max 3.5 ± 0.57 1.90 ± 0.32 3.8 ± 1.1 1.6 ± 0.095 3.8 ± 0.80
Min 0.48 ± 0.014 0.52 ± 0.036 0.52 ± 0.020 0.54 ± 0.046 0.59 ± 0.031
Atomic position fluctuations (Å2) for all Cα or loop Cα atoms. 
Figure 3.1
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Figure 3.2
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Figure 3.3
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Figure 3.4
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Figure 3.5
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Figure 3.6
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Figure 3.7
Figure 3.8
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CHAPTER 4 
 
Active Nuclear Receptors Exhibit Highly Correlated AF-2 Domain Motions 
 
 
4.1 INTRODUCTION 
 
The nuclear receptor (NR) superfamily of ligand-regulated transcription factors 
controls the expression of genes essential to metabolism, development and systemic 
homeostasis [1,2,3].  NRs are modular proteins typically composed of a conserved N- 
terminal Zn-module DNA binding domain (DBD) that targets specific response elements, a 
variable hinge region, and a C-terminal ligand binding domain (LBD) capable in most cases 
of responding to specific small molecule ligands [4].  NR LBDs contain a shallow activation 
function 2 (AF-2) surface formed by helices α3, α3’, α4 and αAF that is essential for ligand-
dependent interactions with transcriptional coregulators.  The AF-2 surface complexes with 
LxxLL-containing transcriptional coactivators in the presence of agonist ligands, and with 
distinct leucine-rich corepressor motifs in the presence of antagonists or in the absence of 
ligand [4,5].  
The pregnane X receptor (PXR) controls the expression of a wide range of gene 
products involved in xenobiotic metabolism and endobiotic homeostasis [6,7,8], and is  
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unusual in the NR superfamily in several respects.  First, PXR responds promiscuously to a 
wide range of chemically-distinct ligands from small lipophilic phenobarbital (232 Da) to the 
large macrolide antibiotic rifampicin (823 Da); in contrast, most NRs are highly specific for 
their cognate ligands [9,10,11].  Second, the PXRs of known sequence contain a 50-60 
residue insert that, as observed in human [12,13,14], creates a unique β-turn-β motif and 
novel PXR homodimer interface.  All NR LBDs fold into a three-layer α-helical sandwich in 
which α10 forms standard homodimerization interactions (e.g., for steroid receptors like the 
estrogen receptor-α, ERα) or heterodimerization interactions (e.g., with RXR for orphan 
receptors like PXR) [2,15,16].  The PXR LBD, in contrast, contains a second oligomerization 
interface at the novel β-turn-β motif in which intercalating tryptophan and tyrosine residues 
(Trp-223/Tyr-225) lock across the dimer to form an aromatic zipper [4,5,12] (Figure 4.1A).  It 
has been shown that this dimer interface is essential to PXR function, and that the specific 
disruption of homodimerization eliminates the ability of the receptor to interact with 
transcriptional coactivators like steroid receptor coactivator 1 (SRC-1), but does not impact 
PXR’s subcellular localization or its association with DNA, RXR, or activating ligands [12].  
This work led to the proposal of a PXR-RXR heterotetramer as the functional unit [12] 
(Figures 4.1A, 4.1B). 
The unique PXR homodimer interface, however, is located more than 30 Å from the 
coactivator binding site at the receptor’s AF-2 surface (Figure 4.1A).  Thus, we hypothesize 
that long-range motions within the PXR LBD are essential for communicating the stabilizing 
effect of PXR homodimerization to the AF-2 domain.  To test this hypothesis, we performed 
all-atom molecular dynamics (MD) simulations on both the PXR LBD, as well as two other 
nuclear receptor LBDs, in various states (Table 4.1).  The former orphan peroxisome 
proliferator-activated receptor-γ (PPARγ ) is functional as a heterodimer with RXR, while the 
steroid estrogen receptor-α (ERα ) is active as an analogous homodimer (Figure 4.1B).  We 
examined LBDs in inactive states (e.g., monomers or mutants), as well as those in the 
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proper functional states (e.g., homo- or heterodimers, or as a heterotetramer for RXR) we 
have termed “active-capable.”  Our results support the conclusion that the NR LBD provides 
a scaffold for long-range motions that prepare the AF-2 surface for binding to transcriptional 
coactivators. 
 
4.2 RESULTS 
 
4.2.1 Stable Dynamic Trajectories   
Six all-atom molecular dynamics (MD) runs were performed for 20-30 ns on three 
nuclear receptor LBDs (Table 4.1).  PXR was examined both as a heterodimer with RXR 
and as a heterotetramer with RXR (30 ns simulations).  Wild-type PPARγ was examined as 
a heterodimer with RXR, and the inactive PPARγP467L mutant was also examined as a 
heterodimer with RXR (20 ns simulations).  Finally, ERα was examined both in its inactive 
monomeric state (20 ns), and as an ERα homodimer (25 ns).  All six trajectories were 
judged as stable by two criteria.  First, the total energy of each system, calculated as the 
sum of kinetic and potential energy at each time point, was found to be essentially constant 
after the first 2-3 ns (Figure 4.2, Supplemental Figure 4.1).  These results indicate that after 
a short period of equilibration, each simulation was sampling an energetically stable 
conformational ensemble.  Second, all trajectories were analyzed in terms of moving 
average all-atom root mean square deviations (RMSDs) from starting crystal structures over 
the simulation time course (Supplemental Figures 4.2, 4.3).  The PXR-RXR trajectories 
exhibited RMSD values of 0.7-5.0 Å (Supplemental Figure 4.2), while the PPARγ- and ERα-
containing trajectories exhibited values of 1.7-3.5 Å (Supplemental Figure 4.3).  Such 
deviations were considered low for systems of this size (e.g., 1044 residues for the PXR-
RXR heterotetramer). The RMSD results indicate that all simulations were stable for at least 
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the last 10 ns of each trajectory (Supplemental Figures 4.2, 4.3).  Thus, the final 10 ns 
section of each simulation was used for subsequent analysis. 
 
4.2.2 Highly Correlated Motion in the PXR-RXR Heterotetramer  
The PXR-RXR heterotetramer is expected to have distinct functional dynamics 
relative to the heterodimer because the heterotetramer contains the unique PXR homodimer 
interface shown to be essential for receptor activity [12] (Figure 4.1).  Thus, we examined 
the PXR LBDs in both the PXR-RXR heterodimer and PXR-RXR heterotetramer simulations 
over the last 10 ns of each trajectory using essential dynamics analysis.  Essential dynamics 
discriminates between concerted motions of residue clusters within a protein and 
uncorrelated residue fluctuations [17].  We computed normalized covariance matrices [18] to 
classify the relationships between all possible residue pairs in the protein (Figure 4.3A).  In 
this analysis, correlation (two residues moving in the same direction) is indicated by residue-
residue correlation coefficients approaching +1, while correlation coefficients approaching -1 
indicate anticorrelation (residues moving in opposite directions).  Correlation coefficients 
near zero, in contrast, are associated with residue pairs that lack a dynamic relationship.   
The PXR LBDs in the PXR-RXR heterotetramer exhibit significantly more residue-residue 
correlation relative to the PXR LBD in the PXR-RXR heterodimer (Figure 4.3A).  Indeed, the 
distribution of correlation coefficients for the PXR LBD in the PXR-RXR heterodimer has one 
peak centered close to zero, indicating the majority of residue-pairs are not correlated (data 
not shown).  In contrast, the correlation coefficient distribution for the PXR LBDs in the PXR-
RXR heterotetramer has two distinct peaks, one positive and one negative, indicating both 
residue-residue correlation and anticorrelation (data not shown).   
Clusters of correlated PXR residues from the PXR-RXR heterodimer and 
heterotetramer that exhibited concerted motion were then examined for the strength of their 
residue-residue correlation coefficients and the biological significance of those dynamics.  
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Clustering the PXR LBDs from the PXR-RXR heterotetramer at a correlation coefficient less 
than 0.6 produced a single cluster containing the complete PXR-RXR homodimer, while 
clustering at a correlation coefficient above 0.8 resulted in clusters comprised of only 2-5 
residues.  Neither coefficient cutoff alone could interrogate the biological relevance of the 
concerted motions; thus, we classified clusters using three correlation coefficient cutoffs 
(Figure 4.3B, C).  Such cutoffs discriminate between weak (0.6 or less), medium (between 
0.6 and 0.7), and strong (between 0.7 and 0.8) correlations between PXR residues.  The 
same cutoffs set in the heterotetramer were used, for consistency, to cluster the relatively 
weak correlated motion observed in the PXR-RXR heterodimer.  Indeed, the PXR LBD from 
the heterodimer exhibited only five small correlated clusters, with smaller regions of these 
weakly correlated clusters remaining at a medium strength correlation coefficient, and only 
one group of a few residues identifiable at a strong correlation coefficient (Figure 4.3B). 
In distinct contrast, however, the PXR LBDs in the PXR-RXR heterotetramer form a 
strongly correlated unit (Figure 4.3C).  The β-sheet region involved in the PXR-PXR 
homodimerization interface (β1, β1’, β3, β4), together with α-helices 1, 3, 3’, 4 and 9, exhibit 
the strongest degree of correlation; the residues of these β-sheets and α-helices are all 
clustered together with a correlation coefficient of 0.8.  The neighboring helices, including 
αAF, also exhibit highly correlated motion with correlation coefficients > 0.6 (Figure 4.3C).  
The strength of residue-residue correlations throughout this region suggest that α3 forms a 
critical conduit through which the stabilizing effects of the homodimer interface involving β1, 
β1’, β3, and β4 are communicated to helices 3, 3’, 4 and AF of the AF-2 surface.  In the 
PXR-RXR heterodimer, however, the same β-sheet region is anticorrelated with the AF-2 
domain (Figure 4.3B).  
 
 
 
133 
 
4.2.3 Highly Correlated Motion in the PXR-RXR Heterotetramer AF-2 Surface  
We next examined the motions in the four helices that create the AF-2 coactivator 
binding surface on PXR: α3, α3’, α4, and αAF.  The concerted motion of this surface was 
compared between the PXR LBDs in the PXR-RXR heterodimer and heterotetramer 
trajectories, and was examined using both quasiharmonic analysis (QHA) and normal mode 
analysis (NMA).  Both methods have benefits and limitations.  For quasiharmonic analysis, 
its benefits are all-atom resolution and the use of explicit solvent, but it is limited by the time 
constraints of all-atom MD.  Normal mode analysis has the benefit of observing motions on a 
longer timescale than available with QHA, but is limited to analyses based upon the coarse 
grained model solely of the macromolecule.  Our results agree with others that it takes more 
NMA modes than QHA modes to describe the same motions [19].  Thus, we employed the 
first two modes from QHA and first 14 nontrivial modes from NMA (see Methods).  
Eigenvectors from these analyses are associated with the magnitude and direction of 
motion, and these eigenvectors can be used to create visuals of the NR’s motion.   
After examining the vectors describing the primary modes of motion derived from 
QHA for each α-carbon position in the PXR LBDs of the PXR-RXR simulations, a single 
average vector was calculated to describe the motion of seven of the eleven α-helices in the 
LBD.  The remaining four helices, α3, α4, αAF and α10, displayed distinct motions at their 
termini; thus, for these helices, two average vectors were employed.  The results of this 
analysis show that the PXR LBD helices from the PXR-RXR heterotetramer move as a 
single unit, and in one direction (Figure 4.4A).  This correlation is especially evident in the 
AF-2 surface, as α3, α3’, α4 and αAF all move together in the same direction (Figure 4.4A 
inset).  In contrast, the PXR LBD from the PXR-RXR heterodimer exhibited relatively small, 
disjointed motions (Figure 4.4B).  This lack of helix-helix correlation includes the AF-2 
surface helices α3, α3’, α4 and αAF (Figure 4.4B inset).   
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AF-2 mobility identified by QHA was also assessed by examining the angles 
between the directions of motion as defined by the eigenvectors for α-carbons of residues 
important to coactivator binding (Table 4.2, Methods).  As such, if two residues in the AF-2 
surface are moving together, the angle between them is small (see Methods, Equation 1).  
The average angle from the sum of motion vectors (modes) 1 and 2 between AF-2 domain 
residues in the PXR-RXR heterodimer simulation was 71.6°.  In contrast, the average angle 
for the same residue pairs in the PXR-RXR heterotetramer simulation was 31.5° (Table 4.2).  
Taken together, these QHA results support the conclusion that the intramolecular β-sheet 
formed by the PXR homodimer interface produces highly correlated AF-2 surface motions in 
the PXR-RXR heterotetramer complex.  
In a second analysis, modes of motion of the AF-2 surface of the PXR LBD were 
examined from both the heterodimer and heterotetramer trajectories using NMA.  Similar to 
the QHA study above, angles between the directions of motion as defined by the 
eigenvectors for α-carbons of residues important to coactivator binding were calculated 
(Table 4.2, Methods).  The average angle observed in the AF-2 surface in the PXR-RXR 
heterotetramer was 13.5° using NMA, even smaller than the average angle found using 
QHA (Table 4.2).  In contrast, the average angle for the same PXR AF-2 residues in the 
PXR-RXR heterodimer was 70.1°, nearly identical to the value found using QHA (Table 4.2).  
Thus, these data support the conclusions of the QHA study, and indicate that a high degree 
of helix-helix correlation is present in the AF-2 surface of the PXR-RXR heterotetramer 
relative to the heterodimer.  Similarities between the QHA and NMA results strengthen this 
collective conclusion, particularly because QHA is based on shorter dynamic movements of 
all atoms, while NMA examines harmonic oscillations that occur on longer time scales. 
Plots of the angles between the vectors of motion of all possible PXR LBD residue 
pairs from both the heterodimer and heterotetramer simulations for the QHA and NMA 
studies are shown in Figures 4.5A and 4.5B, respectively.  Areas in green represent angle 
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values close to zero (vectors moving in the same direction, or correlated), while areas in 
yellow indicate vectors with angles close to 180º (vectors moving in the opposite direction, 
or anticorrelated).  In both plots, a high degree of correlated motion is observed for the PXR 
LBD in the PXR-RXR heterotetramer, while significantly less correlation is observed for the 
LBD in the heterodimer (Figures 4.5A, B).  The similarity between Figures 5A and B, from 
selected modes of QHA- and NMA-identified motion, and Figure 4.3A, from all modes of 
motion, indicates that enough modes were chosen in both QHA and NMA to represent the 
motion of each LBD (Methods).  In addition, both the QHA and NMA plots for the 
heterotetramer indicate similar correlated structural elements.  For example, the PXR β-
sheet moves in a more correlated manner with respect to αAF in the heterotetramer relative 
to the heterodimer (Figures 4.5A, B).  In summary, long-range motions impacted by the 
oligomeric state of PXR play a central role in the function of this nuclear xenobiotic receptor. 
 
4.2.4 Correlated AF-2 Motions in Other Nuclear Receptors  
We next examined whether the unliganded LBDs of other members of the NR 
superfamily would also exhibit correlated AF-2 surface motions.  As stated above, 20-25 ns 
MD simulations were performed on two inactive NR states, the ERα monomer and the 
PPARγ P467L-RXR heterodimer complex, and on two “active-capable” states, the ERα 
homodimer and the wild-type PPARγ-RXR heterodimer.  A P467L mutation has been shown 
to inactivate PPARγ [20].  Only moderate levels of residue-residue correlation and 
anticorrelation were observed for both states of ERα and PPARγ (Supplemental Figures 
4.4A, B).  Examination of correlation coefficient distributions in these simulations reveals 
that all remain close to zero, indicating relatively non-correlated motion (data not shown).   
In spite of their relatively limited overall correlation, however, the active-capable 
forms of ERα and PPARγ-RXR exhibited correlated AF-2 domain motions.  Similar to the 
analysis of the PXR trajectories, both QHA and NMA were employed to examine these ERα 
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and PPARγ simulations.  Results from QHA studies reveal that the active-capable forms of 
ERα, and PPARγ exhibit more correlated AF-2 motions than their inactive counterparts 
(Figure 4.6).  Angles between the vectors describing AF-2 surface helix motions in PPARγ 
and ERα states using both QHA and NMA further support the overall conclusion that active-
capable states exhibit correlated AF-2 surfaces (Table 4.3, 4.4).  For example, the average 
angles for ERα homodimer and wild type PPARγ-RXR determined using NMA are 41.0° and 
48.8°, respectively, while those for the inactive ERα monomer and the PPARγ P467L mutant 
are 63.1° and 58.3°.  Again, the AF-2 correlation in motion observed using the shorter time 
scales of all-atom molecular dynamics simulations and QHA are also seen in the longer 
harmonic oscillations of NMA.  In summary, correlated motion appears to be a consistent 
feature in the AF-2 domains of active-capable nuclear receptor LBDs.  
 
4.3 DISCUSSION 
The differences in human PXR LBD motion between two oligomeric states of the 
receptor (as a heterodimer and a heterotetramer with RXR) were examined using molecular 
dynamics trajectories, essential dynamics, quasiharmonic, and normal mode analyses.  It 
was hypothesized that the PXR heterotetramer, in which PXR LBD monomers form a unique 
homodimer shown to be critical for transcriptional regulation [12], would exhibit functionally-
relevant motion.  Indeed, we find that this “active-capable” form of PXR exhibits not only 
significantly more overall motion and more correlated motion relative to the heterodimer, but 
also highly correlated motion in the AF-2 surface responsible for functionally-essential 
contacts with transcriptional coactivators (Figures 4.4,4.5).  These data suggest that a high 
degree of motion promotes the proper function of this nuclear receptor, provided that the 
motion is correlated to preserve the state of the receptor ready to bind to leucine-rich 
coactivator motifs.   
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In addition, these results indicate that long-range motions are critical to the function 
of the xenobiotic receptor PXR.  The homodimer interface unique to the PXR LBD is located 
approximately 30-35 Å from the AF-2 surface (Figure 4.1).  Essential dynamics have 
revealed that the β-sheet and six α-helices in PXR (1, 3, 3’, 4, 9, AF), including those that 
comprise the AF-2 surface, move as a single unit in the heterotetramer trajectory (Figure 
4.3).  This suggests a structural mechanism by which PXR homodimerization creates a ten-
stranded intermolecular β-sheet (Figure 4.1) that positively impacts AF-2 domain motion.  
The N-terminal portion of α3 appears to serve as a critical bridge between the PXR β-sheet 
and the AF-2 helices, such that correlated α1-α4 motion is “communicated” to α3-α4 and 
αAF (Figure 4.4). This relationship explains how the obligate PXR monomer mutant Trp-
223-Ala/Tyr-225-Ala, in which the interlocking aromatic residues at the homodimer interface 
are eliminated, is still able to bind to ligand, DNA and RXR, but not to transcriptional 
coactivators at the AF-2 surface [12].  
This hypothesized path of “communication through motion” mediated by α3 and 
involving several β-strands, as well as α1 and α 9, correlates well with existing PXR 
structure-function data.  First, Met-243, located in the N-terminal portion of α 3, is contacted 
by ligands in all reported PXR LBD crystal structures [4,21,22].  Thus, they appear critical for 
the ligand-enhanced transcriptional activity exhibited by PXR.  Second, single mutations in 
either α3 or α3’, such as Thr-248-Glu, Lys-277-Gln and Pro-268-His, result in a loss of PXR 
activity [23,24].  In addition, although the α3 double-mutant Lys-277-Gln/Thr-248-Glu 
restores transcriptional activation, it abolishes the antagonism of ketoconazole, 
hypothesized to function by binding the AF-2 surface [24,25].  Third, the α1 and α9 mutants 
Asp-163-Gly and Ala-370-Thr, respectively,  represent a class of PXR variants that are 
distantly located from the AF-2 domain but result in reduced transcriptional activity [26].  
Taken together, these data support the conclusion that the wild-type PXR LBD is “tuned” in 
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its heterotetrameric complex with the RXR LBD to produce correlated motions that promote 
the binding of transcriptional coactivators. 
Extension of this analysis into other nuclear receptors reveals correlated AF-2 
surface motions in “active-capable” forms of ERα and PPARγ (Figure 4.6, Supplemental 
Figure 4.4).  Thus, long-range motions may play critical roles in the LBD activation potential 
of several members of the nuclear receptor superfamily.  Our results expand on previous 
MD investigations of NR LBDs.  For example, dynamics studies on ERα [27] showed that 
the addition of coactivator peptide and ligand to apo ERα lead to increased αAF helix motion 
in unspecified directions.  Similarly, studies on androgen insensitivity syndrome associated 
androgen receptor Pro-892-Ala and Pro-892-Leu mutations revealed via biochemical assays 
and MD simulations an increased flexibility and distortion of the αAF helix [28].  We present 
evidence that the AF-2 domain helices of the Erα, PPARγ, and PXR LBDs move together 
and in the same direction in each receptor.  One may postulate that the uncorrelated motion 
between the helices in the AF-2 domain observed for inactive receptors (e.g., apo PXR-RXR 
heterodimer, ERα monomer and the PPARγ P467L-RXR mutant) may represent the initial 
transition towards an αAF position required for corepressor binding [29].  Alternatively, these 
anticorrelated motions may simply prevent coactivator binding to LBDs that are not in active-
capable oligomeric states. 
The results presented here are also in agreement with limited proteolysis [15], 
fluorescence polarization [20], and NMR [30,31] studies that examined the stabilization of 
global and local motions of ERα [15] and PPARγ [20] upon ligand binding.  Of particular note 
are time-resolved fluorescence polarization studies by Kallenberger and Schwabe [20] on 
the human P467L PPARγ mutant that causes insulin resistance and early onset 
hypertension.  This mutation was found to weaken immobilization of αAF against the main 
body of the receptor.  In our molecular dynamics simulations, wild type PPARγ-RXR 
exhibited a strong degree of correlated AF-2 motion while the PPARγ P467L-RXR mutant 
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showed uncorrelated motion in its AF-2 domain (Figure 4.6).  This is the first model of 
nuclear receptor dynamics that relates changes in motion to a mutation causing a disease 
state. 
While nuclear receptors are well-established targets for small molecule modulators 
that treat a wide range of conditions, current drugs function as agonists and antagonists via 
the ligand binding pocket.  However, recent data have indicated that nuclear receptor LBDs 
can be antagonized using small molecules that block coregulator binding to the AF-2 
surface.  For example, thyroid receptor antagonists discovered by high-throughput 
screening were found to act at the AF-2 site of that receptor [32,33].  In addition, the azole 
family of antifungal compounds has recently been shown to antagonize the action of human 
PXR via the AF-2 domain [24,25].  The dynamics data presented here further elucidate the 
nature of motions essential for AF-2 active-capable function, and may facilitate the improved 
design or development of therapeutics targeted to specific NR AF-2 surfaces. 
 
4.4 METHODS 
Molecular Dynamics Simulations 
Molecular dynamics simulations were run on the apo PXR-RXR LBD heterodimer 
and heterotetramer.  MD simulations were also performed for the nuclear receptors ERα 
(monomer and homodimer) and PPARγ (wild-type heterodimer with RXR and mutant P467L 
heterodimer with RXR).  A summary of these simulations containing their oligomeric states, 
starting structure PDB IDs, and activity is provided in Table 4.1.  All starting structures were 
obtained from the protein databank (www.rcsb.org).  The PXR-RXR heterodimer and 
heterotetramer models as proposed in Noble et. al. [12] were generated by first generating a 
PXR-RXR heterodimer model, followed by overlaying two copies of the heterodimer onto 
each protomer of the PXR homodimer structure.  The PXR-RXR heterodimer model was 
created by superimposing the PXR LBD onto the LBD of PPARγ in the PPARγ-RXRα 
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heterodimer crystal structure (PDBID: 1FM6).  Upon creating this model, the PXR LBD was 
found to make nearly identical salt bridges, hydrogen bonds and hydrophobic interactions 
with the RXRα LBD as seen in the PPARγ-RXRα heterodimer crystal structure.  
All MD simulations were carried out with a 2 fs time step using the AMBER 2003 
force field [34].  Molecular graphics figures were generated in Pymol 
(http://pymol.sourceforge.net).  All production runs employed the PMEMD module from 
Amber 9.0 [35].  Frames were recorded every 0.4 ps.  Topology and parameter files were 
created using the LEaP program within AMBER [35].  The simulation system consisted of 
the protein surrounded by a truncated octahedron of water and sodium ions to maintain 
charge neutrality.  An explicit solvent model was used with TIP3P water molecules filling 
12.5 Å between the surface of each protein and the edge of the box [36]. Electrostatic 
interactions were calculated using the particle-mesh Ewald algorithm [37] with a cutoff of 10 
Å applied to Lennard-Jones interactions.  
The SANDER package within AMBER was used for 5000 steps of energy 
minimization.  Equilibration included 20 ps of constant volume conditions with heating from 
100 to 300 K followed by 100 ps constant temperature conditions.  Constant volume heating 
from 200 to 300 K was applied to the system for 20 ps before beginning the production run 
with the NPT ensemble. 
Simulations were analyzed using the PTRAJ package in Amber [35]. All-atom 
moving average root-mean-square deviations (RMSD) were calculated for each trajectory 
using the initial crystal structure as reference with an interval of 100 data points.  
Quasiharmonic analysis was employed for each trajectory using PTRAJ [35].  
Loop Modeling 
In all PXR simulations, a disordered loop (PDB ID 1ILG, residues 178-197) missing 
from the apo PXR LBD crystal structure was modeled using the MODELLER module of 
InsightII with database searching (www.accelrys.com) [38].  The N and C termini of the 
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modeled loop segment were reconnected to the missing sections of the crystal structure to 
avoid the termini from unrealistic flopping during simulations.  The loop was examined for its 
potential impact on the RMSD from starting crystal structure by analyzing the simulations of 
the PXR LBD with and without the loop.  The loop was found to impact the overall 
magnitude, but not the variability of the RMSD, suggesting that these regions move more 
than others, but do not effect stable conformations sampled during the simulation.  
Therefore, we have omitted the loop from subsequent analyses.  However, we chose to 
include this loop in our simulations because it is a more realistic biological representation of 
the receptor.  
Correlation Analysis  
The pair-wise correlation coefficient as described in Sharma et. al. [18], Cij, was 
computed between α-carbons of two residues, i and j, with values ranging from -1 to +1.  
The more positive the value of Cij, the more correlated (moving in the same direction with 
one another) the two residues, i and j, move.  Likewise, the more negative the value of Cij, 
the more anticorrelated (moving in the opposite direction to one another) the two residues, i 
and j, move.  The single-linkage clustering method [39] was applied to identify distinct sets 
of residues that move correlated with each other or anticorrelated to each other.  In this 
method, a graph is initially built where each entity corresponds to individual residues.  The 
clustering method proceeds by first finding two entities that have the highest similarity (i.e., 
the correlation coefficient) between them.  After clustering those two entities into one, the 
similarities between this new entity and the rest are updated.  This process is repeated until 
there are no more entities to cluster or the correlation coefficient cutoff is satisfied.  In a 
single-linkage clustering method, the similarity between two clusters is defined as the largest 
similarity or the highest correlation coefficient between any two members from the two 
clusters.  
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Angle Analysis 
Residues chosen to describe motion in Tables 4.2-4 were not chosen at random in 
the AF-2 domain of PXR LBD.  Glu-427 of αAF and Lys-259 of α3 are the “charge clamp” 
residues of PXR; the charge clamp is a common structural motif in nuclear receptor-
coactivator interactions and involves contacts between the LBD and the termini of the 
coactivator LxxLL helix.  Lys-277 of α4 was chosen because it is conserved in many 
receptors and Leu-424 of αAF directly contacts the coactivator SRC-1 [14].  Angle analysis 
was performed using Equation 1 to find the average angle between vectors for α-carbon a 
and b. 
             
  


  
ba
bacosθ 1 

                                                           (1) 
Quasiharmonic Analysis 
The effective modes of vibrational motion can be obtained using quasiharmonic 
analysis by calculating a force field relative to the average structure based on the 
fluctuations generated from an MD simulation.  Quasiharmonic modes, unlike standard 
principal component methods, are mass weighted just as normal modes and thus may be 
compared directly with normal mode analysis.  However in quasiharmonic modes, 
anharmonic effects are implicitly included and thus may be different from normal modes [40].  
The percent contribution of each quasiharmonic analysis mode to the overall motion can be 
evaluated by analyzing the eigenvalues of the first 50 modes.  The percent contribution of 
each mode can be determined by taking the reciprocal of the eigenvalue of one mode and 
dividing by the sum of the inverse eigenvalues for all 50 modes.  The eigenvalue is 
equivalent to the square of the frequency (cm-1).  The percent contribution of each mode 
(Supplemental Figure 4.5) drops off quickly with only the first few modes showing any 
significant contribution to the overall motion.  Modes 1 and 2 in the PXR-RXR heterodimer 
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and heterotetramer simulations represent proximal percent contributions, while in ERα and 
PPARγ-RXR simulations mode 2 contributed 50% less to overall motion than mode 1 
(Supplemental Figure 4.5).  In order to sample the most relevant motions, the first two 
modes were analyzed for PXR-RXR simulations and only the first mode was analyzed in the 
ERα and PPARγ-RXR simulations.  In all cases, the first mode(s) were sufficient to describe 
between 18-33% of the overall motion (Supplemental Figure 4.5).  To simplify analysis of 
the PXR-RXR simulations, the sums of the x, y and z vector components of each atom in 
each mode were obtained and weighted against the percent contribution. 
Normal Mode Analysis 
Normal mode analysis (NMA) is based on a harmonic approximation of the potential 
energy function around a minimum energy conformation [41,42].  ELNEMO uses a Hookean 
potential described by Tirion [41,43], which assumes that the total energy potential function 
of the reference 3D structure (in this case the crystal structure) is at an energy minimum.  In 
NMA, the lowest energy modes (below 30-100 cm-1) have the largest contribution to the 
amplitude of atomic displacements.  However the first six normal or vibrational modes 
represent rotational and translational motion and are disregarded [44].  
Normal mode theory has been shown to accurately describe large conformational 
transitions in proteins such as hexokinase [45], lysozyme [46,47] and citrate synthase [48] 
which occur at microsecond or millisecond time scales.  Fifty normal modes were generated 
using the ELNEMO server for each state of the three nuclear receptors [44]. The only 
change made was the removal of the modeled loop region (residues 178-197) in the PXR-
RXR complexes, as these residues resulted in low frequency modes with low collectivity.  
Collectivity is a measure of the fraction of residues affected by a given mode.  Computed 
normal modes sometimes have localized motion that corresponds to extended parts of the 
protein and are usually ignored [44].  This was done to confirm that the high degree of 
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correlated motion we observed in simulations involving the active-capable forms of nuclear 
receptors were relevant at longer time scales.  
Just as in the quasiharmonic analysis of the all-atom molecular dynamics 
simulations, we first sought to determine the minimum number of modes required to obtain 
an accurate description of the overall motion. Supplemental Figure 4.6 shows the percent 
contribution of each mode, up to the first 50 modes.  The first six modes of motion are trivial 
and have been removed from the analysis.  Except for the tetramer, the percent contribution 
of each of the normal modes appears to drop off more slowly than those of the QH analysis 
(Supplemental Figures 4.5, 4.6). We chose to analyze modes 7-20, which describe from 48-
81% of the overall motion of each nuclear receptor (Supplemental Figure 4.6).  To simplify 
the analysis of the modes, we calculated the vector sum of each atom for modes 7-20, 
weighted by the percent contribution of each mode.  
 
 
4.5 ACKNOWLEDGEMENTS 
We thank C.D. Fleming, L.M. Guogas, J. Orans, E.A. Ortlund and S. Lujan for helpful 
advice, P. Wassam, M. Johnson, J. Bischof, and S. Ramachandran for their experimental 
and computational assistance. 
 
4.6 FIGURE LEGENDS 
 
Figure 4.1. Structural Features of the PXR-RXR Heterotetramer. (A) A model of the PXR 
(blue, magenta, green)-RXR (yellow) heterotetramer highlights the PXR homodimer 
interface and the ten-stranded intermolecule β-sheet formed between the two monomers.  
PXR residues Trp-223 and Tyr-225 central to homodimerization are rendered in yellow with 
transparent CPK spheres. The -helices 3, 3’, 4 and αAF (green) create the AF-2 surfaces 
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that bind leucine-rich coactivator peptides like SRC-1 (orange) using a charge clamp (Lys-
259, Glu-427) and other residues (light pink). (B) Schematics of the oligomeric NR 
complexes examined in this paper.  
 
Figure 4.2 Conservation of Total Energy During PXR-RXR Simulations. Total energy 
(kcal/mol), used as a measure of overall simulation stability, remains relatively constant 
during the course of both the PXR-RXR heterodimer (A) and PXR-RXR heterotetramer (B) 
simulations, particularly during the final 10 ns used for analysis (boxed).  Both the total 
energy (grey diamonds) and a running average (black line) are shown. 
 
Figure 4.3. Highly Correlated Motion in the PXR-RXR Heterotetramer.  (A) Covariance 
analysis of the PXR LBD in the PXR-RXR heterodimer and heterotetramer.  Residue-
residue correlation coefficient values range from blue (anticorrelated, -0.9) to red 
(correlated, +1), with uncorrelated residue pairs in yellow. Secondary structure is provided 
from right-to-left, and bottom-to-top. (B) Clustering of correlated PXR LBD residues from the 
PXR-RXR heterodimer simulation.  Eleven clusters were identified, five with a correlation 
cutoff (CC) of 0.6, five with a CC of 0.7, and one with a CC of 0.8. C. Clustering of correlated 
PXR LBD residues from the PXR-RXR heterotetramer simulation.  Three clusters were 
identified, one each with CCs of 0.6, 0.7, and 0.8.  Clusters are colored by the maximum 
correlation coefficient at which they are observed. 
  
Figure 4.4 Correlated AF-2 Domain Motions in the PXR-RXR Heterotetramer.  Vectors 
describing the motions of PXR LBD -helices from the heterotetramer (A) and heterodimer 
(B) simulations show the active-capable heterotetramer PXR LBD exhibits more overall 
correlated motion as well as correlation between AF-2 surface helices.  Each helix 
eigenvector (shown by an arrow) is the sum of the α-carbon eigenvectors in that helix. All 
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arrows were generated using the same scalar magnifications of motion vectors and are 
presented on the same scale.  As such, they represent relative, rather than absolute, 
movements.  
 
Figure 4.5 Quasiharmonic and Normal Mode Analyses.  Angles between motion vectors 
for all residue pairs in the PXR-RXR heterodimer and heterotetramer.  Motion vectors were 
identified by quasiharmonic analysis (QHA, using the first two modes; (A) and by normal 
mode analysis (NMA, using the first 14 nontrivial modes; (B)).  In the plots, green represents 
angles close to zero (correlated), while yellow indicates angles close to 180º 
(anticorrelated).  
 
Figure 4.6 AF-2 Surface Motions in PPARγ and ERα Complexes.  Similar to Figure 4.4, 
the active-capable PPARγ-RXR heterodimer and ERα homodimer complexes exhibit 
correlated motions in their AF-2 surfaces during MD trajectories (A, C), while inactive states 
of both receptors exhibit reduced AF-2 surface correlation (B, D).   
 
4.7 SUPPLEMENTAL FIGURE LEGENDS 
 
Supplemental Figure 4.1 Conservation of Total Energy During ERα and PPARγ-RXR 
Simulations.  Total energy (kcal/mol), used as a measure of overall simulation stability, 
remains relatively constant during the course of both ERα and PPARγ-RXR simulations.  
The final 10 ns (boxed) were used for analysis.  Both the total energy (grey diamonds) and a 
running average (black line) are shown. 
 
Supplemental Figure 4.2 Root Mean Square Deviations from Starting Crystal 
Structures of PXR LBD Trajectories.  Both the all-atom RMSD raw data (grey) and moving 
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average (black, dashed line; blue, solid line) are plotted for PXR-RXR simulations.  Both 
trajectories have stable RMSDs after approximately 15 ns. The most stable section of the 
trajectories, 20-30 ns (boxed), was used for analysis.   
 
Supplemental Figure 4.3 Root Mean Square Deviations from Starting Crystal 
Structures of ERα and PPARγ Simulations.  ERα monomer, PPARγ-RXR wild-type, and 
PPARγ P467L-RXR simulations were stable after 10 ns; data from 10-20 ns (boxed) were 
used in analysis.  The ERα homodimer simulation was stable after 15 ns; data from 15-25 
ns (boxed) were used in analysis.  Moving averages without raw data are plotted to provide 
clearer visualization.   
 
Supplemental Figure 4.4 Normalized Covariance Matrices for ERα and PPARγ 
Simulations. Correlation/anticorrelation versus secondary structure is shown for ERα 
monomer versus ERα homodimer (A) and the PPARγ P467L-RXR mutant heterodimer 
versus wild-type PPARγ -RXR heterodimer (B).  Correlation coefficient values are displayed 
using colors ranging from blue (completely anticorrelated, -0.9) to red (completely 
correlated, +1) with uncorrelated residue pairs in yellow.  Secondary structure is provided 
from left-to-right and bottom-to-top. 
 
Supplemental Figure 4.5 Percent Contribution to Total Motion by Each Mode of 
Motion Using Quasiharmonic Analysis (First 50 Modes).  Modes 1 and 2 were used to 
analyze motion in the PXR-RXR simulations; only mode 1 was used for all other simulations.   
 
Supplemental Figure 4.6 Percent Contribution to Total Motion by Each Mode of 
Motion Using Normal Mode Analysis (First 50 modes).  In normal mode analysis, the first 
six modes of motion are trivial and have been removed from analysis (Methods).  Except for 
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the PXR-RXR heterotetramer, the percent contribution of each of the normal modes appears 
to drop off more slowly than those in the quasiharmonic analysis.  Modes 7-20 were used for 
analysis, which describe from 48-81% of the overall motion for each nuclear receptor.  
 
 
 
 
 
 
 
 
Table 4.1
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Summary of MD Simulations
Receptor/Oligomeric State PDB ID Length of Simulation Activity of State
Total 
Time
Period Used in 
Analysis
PXR-RXR heterodimer* 1ILG 30 ns 20-30 ns Inactive
PXR-RXR heterotetramer* 1ILG 30 ns 20-30 ns Active-capable
PPARγ467L-RXR heterodimer 1RDT** 20 ns 10-20 ns Inactive
PPARγ-RXR heterodimer 1RDT 20 ns 10-20 ns Active-capable
ERα monomer 1ERE 20 ns 10-20 ns Inactive
ERα dimer 1ERE 25 ns 15-25 ns Active-capable
*All PXR simulations are based on 1ILG with residues 178-197 modeled in InsightII.
**Single-site mutant of PPARγ generated in Pymol. There is no crystal structure of the mutant.
Table 4.2
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θ Angle Analysis of α-carbons of PXR LBD
QHA NMA
Active-capable Inactive Active-capable Inactive
PXR from 
Heterotetramer
PXR from 
Heterodimer
PXR from 
Heterotetramer
PXR from 
Heterodimer
Lys277 (α4) Lys259 (α3) 21.0º 70.2º 7.4º 84.5º
Lys259 (α3) Glu427 (αAF) 47.9º 83.6º 9.7º 104.7º
Lys259 (α3) Leu424 (αAF) 43.6º 65.1º 23.4º 133.3º
Lys277 (α4) Glu427 (αAF) 31.5º 66.9º 6.4º 20.6º
Lys277 (α4) Leu424 (αAF) 32.1º 99.0º 20.2º 48.8º
Leu424 (αAF) Glu427 (αAF) 12.8º 45.0º 13.9º 28.8º
Average 31.5º 71.6º 13.5º 70.1º
a
 b

Table 4.3
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θ Angle Analysis of  α-carbons of PPARγ LBD 
QHA NMA
Active-capable Inactive Active-capable Inactive
WT          
PPARγ-RXR
P467L    
PPARγ-RXR
WT           
PPARγ-RXR  
P467L       
PPARγ-RXR
Lys277 (α4) Lys259 (α3) 3.9º 39.4º 29.2º 0.9º
Lys259 (α3) Glu427 (αAF) 1.8º 40.2º 61.8º 35.8º
Lys259 (α3) Leu424 (αAF) 1.2º 37.0º 79.6º 104.1º
Lys277 (α4) Glu427 (αAF) 4.0º 70.1º 44.2º 36.0º
Lys277 (α4) Leu424 (αAF) 3.0º 49.2º 60.3º 104.1º
Leu424 (αAF) Glu427 (αAF) 1.3º 26.6º 17.9º 68.7º
Average 2.5º 48.8º 48.8º 58.3º
a

b

Table 4.4
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θ Angle Analysis of  α-carbons of ERα LBD 
QHA NMA
Active-
capable Inactive 
Active-
capable Inactive
ERα
Dimer
ERα
Monomer
ERα
Dimer
ERα
Monomer
Lys277 (α4) Lys259 (α3) 26.0º 117.8º    47.0º 48.9º
Lys259 (α3) Glu427 (αAF) 52.1º 94.5º 59.8º 83.4º
Lys259 (α3) Leu424 (αAF) 47.0º 122.1º 58.1º 96.8º
Lys277 (α4) Glu427 (αAF) 28.9º 54.1º 30.7º 59.2º
Lys277 (α4) Leu424 (αAF) 64.0º 39.1º 38.0º 74.4º
Leu424 (αAF) Glu427 (αAF) 51.4º 28.2º 12.6º 15.6º
Average 44.9º 76.0º 41.0º 63.1º
a

b

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